| Symbol | BMYMP |
|---|---|
| Name | BRISTOL-MYERS SQUIBB CO. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | - |
| Address | 08543 United States NJ Route 206 & Province Line Road |
| Telephone | (609) 252-4621 |
| Fax | — |
| — | |
| Website | http://www.bms.com |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0000014272 |
| Description | Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power. Additional info from NASDAQ: |
2026-03-12 20:24
Hickey Benjamin 🟢 acquired 28.6K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000006
Read more
2026-03-12 20:23
Shibutani Hiroshi Chris 🟢 acquired 19.6K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more
2026-03-12 20:23
Massacesi Cristian 🟢 acquired 65.3K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more
2026-03-12 20:20
Plenge Robert M 🟡 adjusted position in 33.1K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more
2026-03-12 20:19
Meyers Gregory Scott 🟡 adjusted position in 48.3K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000004
Read more
2026-03-12 20:18
Lenkowsky Adam 🟡 adjusted position in 64.3K shares (6 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more
2026-03-12 20:17
Hoch Lynelle 🟡 adjusted position in 11.6K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more
2026-03-12 20:16
Gallman Cari 🟡 adjusted position in 60.4K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000003
Read more
2026-03-12 20:15
Poole Ahn Amanda 🟡 adjusted position in 33.8K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more
2026-03-12 20:13
Elkins David V 🟡 adjusted position in 47.0K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT03723096 | Expanded Access for CC-4047 | — | Multiple Myeloma | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT00380835 | Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast… | Phase2 | Metastatic Breast Cancer | Withdrawn | — | 2007-12-01 | ClinicalTrials.gov |
| NCT00002157 | Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wa… | Na | HIV Infections | Completed | — | — | ClinicalTrials.gov |
| NCT00002127 | A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety … | Phase2 | HIV Infections | Completed | — | — | ClinicalTrials.gov |
| NCT00000812 | A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerabilit… | Phase1 | HIV Infections | Completed | — | 2000-07-01 | ClinicalTrials.gov |
| NCT01632826 | Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patie… | — | Multiple Myeloma | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT03724227 | Expanded Access for ACE-011 | — | Myelodysplastic Syndrome | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT03723148 | Individual Patient Compassionate Use of Fedratinib | — | Myelofibrosis | Available | — | — | ClinicalTrials.gov |
| NCT04771078 | Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleuce… | — | Multiple Myeloma | Available | — | — | ClinicalTrials.gov |
| NCT03723135 | Expanded Access for CC-486 | — | Acute Myelogenous Leukemia (AML) | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT07032714 | Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma | Phase1 | Relapsed Refractory Multiple Myeloma (RRMM) | Recruiting | 2025-12-19 | 2028-07-01 | ClinicalTrials.gov |
| NCT06348108 | Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Re… | Phase1 | Multiple Myeloma | Recruiting | 2025-07-28 | 2029-07-31 | ClinicalTrials.gov |
| NCT06518551 | Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM | Phase1 | Myeloma | Recruiting | 2024-11-01 | 2034-12-31 | ClinicalTrials.gov |
| NCT06425302 | A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With … | Phase2 | Lymphoma, Follicular | Active_Not_Recruiting | 2024-08-30 | 2028-11-27 | ClinicalTrials.gov |
| NCT06411730 | A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Adminis… | Phase1 | Healthy Participants | Completed | 2024-05-31 | 2024-10-28 | ClinicalTrials.gov |
| NCT06417229 | Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS… | Phase1 | Healthy Participants | Completed | 2024-05-28 | 2025-02-19 | ClinicalTrials.gov |
| NCT06232707 | A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of C… | Phase3 | Multiple Myeloma | Withdrawn | 2024-05-03 | 2030-09-21 | ClinicalTrials.gov |
| NCT06363630 | A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconaz… | Phase1 | Healthy Volunteers | Completed | 2024-04-23 | 2024-08-29 | ClinicalTrials.gov |
| NCT06313996 | A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of… | Phase3 | Relapsed or Refractory Follicular Lymphoma | Withdrawn | 2024-03-29 | 2031-10-16 | ClinicalTrials.gov |
| NCT06318676 | A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With R… | Phase1 | Renal Impairment | Completed | 2024-03-21 | 2024-11-15 | ClinicalTrials.gov |
| NCT06170723 | A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels … | Phase1 | Healthy Participants | Completed | 2024-03-18 | 2024-05-25 | ClinicalTrials.gov |
| NCT06227975 | A Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Adminis… | Phase1 | Healthy Volunteers | Completed | 2024-02-02 | 2024-04-03 | ClinicalTrials.gov |
| NCT06205290 | A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Inves… | Phase3 | Leukemia, Lymphocytic, Chronic, B-Cell | Withdrawn | 2024-01-16 | 2031-10-13 | ClinicalTrials.gov |
| NCT06045806 | A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenal… | Phase3 | Multiple Myeloma | Active_Not_Recruiting | 2023-10-16 | 2029-11-20 | ClinicalTrials.gov |
| NCT05899738 | A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Form… | Phase1 | Healthy Volunteers | Completed | 2023-05-18 | 2023-07-06 | ClinicalTrials.gov |
| NCT05611047 | Telerehabilitation of Multidomain Cognitive Impairment in Multiple Sclerosis | Na | Multiple Sclerosis | Terminated | 2023-02-21 | 2025-02-19 | ClinicalTrials.gov |
| NCT05408026 | Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients Wi… | Phase1 | Relapsed or Refractory Multiple Myeloma | Withdrawn | 2022-10-01 | 2026-02-01 | ClinicalTrials.gov |
| NCT05384691 | Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Side… | Phase2 | Myelodysplastic Syndromes | Recruiting | 2022-09-27 | 2027-07-31 | ClinicalTrials.gov |
| NCT04991935 | Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic… | Phase3 | Eosinophilic Esophagitis | Completed | 2022-08-09 | 2025-08-14 | ClinicalTrials.gov |
| NCT04975997 | Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) V… | Phase3 | Multiple Myeloma | Active_Not_Recruiting | 2022-06-23 | 2032-06-25 | ClinicalTrials.gov |
| NCT05175352 | A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Pa… | Phase1 | Eosinophilic Esophagitis | Completed | 2022-06-07 | 2024-10-11 | ClinicalTrials.gov |
| NCT05214768 | A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent… | Phase3 | Eosinophilic Gastroenteritis | Completed | 2022-03-04 | 2025-08-22 | ClinicalTrials.gov |
| NCT04860466 | A Dose Finding Study of CC-96673 in Participants With Relapsed or Refractory No… | Phase1 | Lymphoma, Non-Hodgkin | Terminated | 2022-01-20 | 2024-07-31 | ClinicalTrials.gov |
| NCT05282459 | Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 M… | Phase1 | Leukemia | Completed | 2022-01-12 | 2025-03-03 | ClinicalTrials.gov |
| NCT04885894 | An Examination of Cognitive Fatigue Using Functional Neuroimaging | — | Multiple Sclerosis, Relapsing-Remitting | Unknown | 2022-01-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT04951778 | Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participa… | Phase1 | Leukemia, Myeloid, Acute | Terminated | 2021-12-02 | 2025-07-30 | ClinicalTrials.gov |
| NCT04887857 | A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine)… | Phase1 | Leukemia, Myeloid, Acute | Completed | 2021-12-01 | 2024-01-08 | ClinicalTrials.gov |
| NCT05028634 | Safety Study to Evaluate Immune Response of Vaccines in Participants With Relap… | Phase3 | Multiple Sclerosis | Completed | 2021-11-11 | 2023-11-15 | ClinicalTrials.gov |
| NCT04982471 | Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort… | — | Lymphoma, Non-Hodgkin | Terminated | 2021-11-03 | 2023-08-03 | ClinicalTrials.gov |
| NCT04272333 | Intratumoral Microdosing of Motolimod in HNSCC | Early_Phase1 | HNSCC | Terminated | 2021-10-15 | 2022-03-25 | ClinicalTrials.gov |
| NCT04748848 | A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combinatio… | Phase1 | Leukemia, Myeloid | Terminated | 2021-10-14 | 2022-03-09 | ClinicalTrials.gov |
| NCT04882163 | Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polat… | Phase1 | Lymphoma, B-Cell | Withdrawn | 2021-10-10 | 2029-04-07 | ClinicalTrials.gov |
| NCT04975399 | Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With … | Phase1 | Multiple Myeloma | Terminated | 2021-10-05 | 2024-06-18 | ClinicalTrials.gov |
| NCT05065541 | Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availabilit… | Phase1 | Healthy Volunteers | Completed | 2021-09-24 | 2024-01-29 | ClinicalTrials.gov |
| NCT04947579 | A Study of CC-99677 in Participants With Active Ankylosing Spondylitis | Phase2 | Spondylitis, Ankylosing | Terminated | 2021-08-25 | 2023-02-21 | ClinicalTrials.gov |
| NCT04958291 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynami… | Phase1 | Healthy Volunteers | Completed | 2021-08-03 | 2021-12-07 | ClinicalTrials.gov |
| NCT04973280 | Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Am… | — | Myelodysplastic Syndromes | Completed | 2021-07-26 | 2022-07-21 | ClinicalTrials.gov |
| NCT04978298 | Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment… | Phase1 | Healthy Volunteers | Completed | 2021-07-19 | 2023-02-26 | ClinicalTrials.gov |
| NCT04789655 | Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leu… | Phase1 | Leukemia, Myeloid | Terminated | 2021-06-16 | 2025-04-14 | ClinicalTrials.gov |
| NCT04771858 | Digital Gait Analysis in the Home Environment of Patients With Multiple Scleros… | — | Multiple Sclerosis | Completed | 2021-03-09 | 2023-06-28 | ClinicalTrials.gov |
| NCT04753697 | A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent… | Phase3 | Eosinophilic Esophagitis | Completed | 2021-02-22 | 2024-08-29 | ClinicalTrials.gov |
| NCT04747236 | Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investiga… | Phase2 | PTCL | Recruiting | 2021-02-19 | 2030-06-02 | ClinicalTrials.gov |
| NCT04392037 | Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone | Phase2 | Multiple Myeloma | Active_Not_Recruiting | 2021-02-17 | 2027-12-01 | ClinicalTrials.gov |
| NCT04839809 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formul… | Phase1 | Healthy Volunteers | Completed | 2021-01-19 | 2021-10-08 | ClinicalTrials.gov |
| NCT04281498 | Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase My… | Phase2 | Accelerated/Blast-phase Myeloproliferative Neoplasm | Completed | 2021-01-14 | 2023-05-30 | ClinicalTrials.gov |
| NCT04434196 | A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutu… | Phase1 | Lymphoma, Non-Hodgkin | Completed | 2020-12-21 | 2024-05-21 | ClinicalTrials.gov |
| NCT04639115 | A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Mode… | Phase1 | Liver Diseases | Completed | 2020-12-18 | 2022-04-06 | ClinicalTrials.gov |
| NCT04618081 | Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractor… | — | Lymphoma Nonhodgkin | Completed | 2020-12-17 | 2025-03-27 | ClinicalTrials.gov |
| NCT04655898 | Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects | Phase1 | Healthy Volunteer | Completed | 2020-12-16 | 2021-03-11 | ClinicalTrials.gov |
| NCT04477850 | A Study to Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-5… | Phase2 | Myelodysplastic Syndromes | Unknown | 2020-11-30 | 2026-02-23 | ClinicalTrials.gov |
| NCT04573582 | Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate a… | Phase1 | Hepatic Impairment | Completed | 2020-11-13 | 2023-03-08 | ClinicalTrials.gov |
| NCT04464798 | A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Ant… | Phase1 | Lymphoma | Terminated | 2020-11-11 | 2025-01-09 | ClinicalTrials.gov |
| NCT04092179 | Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers | Phase1 | Acute Myeloid Leukemia | Terminated | 2020-11-05 | 2023-10-26 | ClinicalTrials.gov |
| NCT04578600 | CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refrac… | Phase1 | Indolent B-Cell Non-Hodgkin Lymphoma | Completed | 2020-10-23 | 2025-02-21 | ClinicalTrials.gov |
| NCT04009109 | Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligib… | Phase2 | Myeloma, Multiple | Active_Not_Recruiting | 2020-10-21 | 2027-06-01 | ClinicalTrials.gov |
| NCT04560738 | A Study to Evaluate the Metabolism and Excretion of [14C]-CC-92480 in Healthy M… | Phase1 | Healthy Volunteers | Completed | 2020-10-15 | 2021-05-13 | ClinicalTrials.gov |
| NCT04528290 | A Study to Evaluate the Relative Bioavailability of a Pediatric Granule Formula… | Phase1 | Healthy Volunteers | Completed | 2020-10-07 | 2021-06-01 | ClinicalTrials.gov |
| NCT04718636 | A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Cont… | Phase1 | Healthy Volunteers | Completed | 2020-09-30 | 2021-08-03 | ClinicalTrials.gov |
| NCT04405102 | COVID-19 Ozanimod Intervention Study | Phase2 | COVID-19 | Terminated | 2020-09-16 | 2022-05-12 | ClinicalTrials.gov |
| NCT04287855 | Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexame… | Phase2 | Multiple Myeloma in Relapse | Unknown | 2020-08-28 | 2026-04-15 | ClinicalTrials.gov |
| NCT04522895 | IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT | Phase2 | Leukemia, Myeloid, Acute | Completed | 2020-08-27 | 2024-07-24 | ClinicalTrials.gov |
| NCT04676945 | Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients | — | Myelodysplastic Syndromes | Completed | 2020-08-21 | 2022-11-21 | ClinicalTrials.gov |
| NCT04336982 | A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Mye… | Phase1 | Leukemia, Myeloid, Acute | Terminated | 2020-08-05 | 2024-04-05 | ClinicalTrials.gov |
| NCT03720041 | Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With … | Phase3 | Multiple Myeloma | Unknown | 2020-08-04 | 2024-12-01 | ClinicalTrials.gov |
| NCT04350463 | A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjec… | Phase2 | Neoplasms | Completed | 2020-07-14 | 2023-12-19 | ClinicalTrials.gov |
| NCT04245839 | A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With R… | Phase2 | Lymphoma, Non-Hodgkin | Active_Not_Recruiting | 2020-07-14 | 2031-09-30 | ClinicalTrials.gov |
| NCT04102449 | Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis… | Phase4 | Psoriatic Arthritis | Withdrawn | 2020-07-01 | 2022-02-01 | ClinicalTrials.gov |
| NCT04196491 | A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diag… | Phase1 | Multiple Myeloma | Completed | 2020-05-27 | 2023-06-07 | ClinicalTrials.gov |
| NCT04257448 | Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Che… | Phase1 | Pancreas Cancer | Completed | 2020-05-25 | 2024-07-02 | ClinicalTrials.gov |
| NCT04241276 | A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer | Phase2 | Pancreatic Cancer | Active_Not_Recruiting | 2020-04-30 | 2029-02-28 | ClinicalTrials.gov |
| NCT03920995 | Multi-center Database Registry to Study Thalamus Changes Using AI in MS | — | Multiple Sclerosis | Completed | 2020-04-01 | 2023-10-31 | ClinicalTrials.gov |
| NCT04297124 | A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy M… | Phase1 | Healthy Volunteer | Completed | 2020-03-11 | 2021-06-04 | ClinicalTrials.gov |
| NCT04140305 | Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Scler… | Phase3 | Multiple Sclerosis | Terminated | 2020-01-16 | 2025-05-15 | ClinicalTrials.gov |
| NCT04113018 | Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone … | Phase2 | Multiple Myeloma | Active_Not_Recruiting | 2020-01-10 | 2027-10-01 | ClinicalTrials.gov |
| NCT04231435 | Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substr… | Phase1 | Healthy Volunteers | Completed | 2019-12-18 | 2020-02-21 | ClinicalTrials.gov |
| NCT03881735 | Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leuke… | Phase2 | Blasts Under 5 Percent of Peripheral Blood White Cells | Withdrawn | 2019-12-02 | 2022-11-19 | ClinicalTrials.gov |
| NCT02434965 | Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With S… | Phase2 | Severe Hypoxic-ischemic Encephalopathy | Withdrawn | 2019-12-01 | 2022-01-01 | ClinicalTrials.gov |
| NCT04036448 | A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- o… | — | Myelodysplastic Syndromes | Completed | 2019-11-28 | 2023-08-15 | ClinicalTrials.gov |
| NCT04119362 | PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pa… | — | Pancreatic Adenocarcinoma | Completed | 2019-10-24 | 2023-06-30 | ClinicalTrials.gov |
| NCT04096105 | Japanese Pharmacokinetic Bridging Study for CC-93538 | Phase1 | Healthy Volunteers | Completed | 2019-10-14 | 2020-01-30 | ClinicalTrials.gov |
| NCT03863184 | Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL | Phase2 | Mantle Cell Lymphoma | Active_Not_Recruiting | 2019-10-11 | 2028-05-30 | ClinicalTrials.gov |
| NCT04161456 | Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Congloba… | Phase2 | Acne Conglobata | Completed | 2019-10-09 | 2021-02-08 | ClinicalTrials.gov |
| NCT04149678 | Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Acti… | Phase1 | Healthy Volunteers | Completed | 2019-10-04 | 2019-12-26 | ClinicalTrials.gov |
| NCT03989414 | A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safet… | Phase1 | Multiple Myeloma | Active_Not_Recruiting | 2019-09-30 | 2026-11-30 | ClinicalTrials.gov |
| NCT03656666 | The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Geni… | Phase2 | Lichen Planus of Vulva | Unknown | 2019-09-24 | 2023-12-31 | ClinicalTrials.gov |
| NCT03376477 | Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patient… | Phase2 | Multiple Myeloma | Terminated | 2019-09-23 | 2025-05-30 | ClinicalTrials.gov |
| NCT03952039 | An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy i… | Phase3 | Primary Myelofibrosis | Completed | 2019-09-09 | 2025-07-28 | ClinicalTrials.gov |
| NCT03983161 | A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Modera… | Phase1 | Healthy Volunteers | Completed | 2019-09-04 | 2023-01-05 | ClinicalTrials.gov |
| NCT04097704 | Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort | — | Hepatic Insufficiency | Completed | 2019-09-04 | 2019-11-01 | ClinicalTrials.gov |
| NCT04036461 | A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relap… | Phase1 | Multiple Myeloma | Terminated | 2019-08-26 | 2024-08-19 | ClinicalTrials.gov |
| NCT04048876 | Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-… | Phase2 | Non-alcoholic Fatty Liver Disease | Terminated | 2019-08-14 | 2021-09-28 | ClinicalTrials.gov |
| NCT03915444 | Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Ade… | Phase2 | Pancreatic Ductal Adenocarcinoma | Completed | 2019-07-15 | 2023-01-23 | ClinicalTrials.gov |
| NCT03906526 | A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Comb… | Phase1 | Carcinoma, Squamous Cell | Terminated | 2019-07-03 | 2022-01-24 | ClinicalTrials.gov |
| NCT03815279 | A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myel… | Phase2 | Multiple Myeloma | Enrolling_By_Invitation | 2019-06-24 | 2028-01-01 | ClinicalTrials.gov |
| NCT03983239 | Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healt… | Phase1 | Healthy Volunteers | Completed | 2019-06-21 | 2019-11-06 | ClinicalTrials.gov |
| NCT03745222 | A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizu… | Phase3 | Carcinoma, Non-Small-Cell Lung | Terminated | 2019-05-22 | 2019-06-26 | ClinicalTrials.gov |
| NCT03900715 | An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Ane… | Phase2 | Myelodysplastic Syndromes | Completed | 2019-05-20 | 2023-03-01 | ClinicalTrials.gov |
| NCT03930953 | A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination W… | Phase1 | Lymphoma, Non-Hodgkin | Active_Not_Recruiting | 2019-05-20 | 2028-02-09 | ClinicalTrials.gov |
| NCT03834623 | Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma | Phase2 | Melanoma | Completed | 2019-05-14 | 2021-08-04 | ClinicalTrials.gov |
| NCT03785184 | A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of … | Phase2 | Multiple Myeloma | Withdrawn | 2019-04-29 | 2019-08-22 | ClinicalTrials.gov |
| NCT03780504 | Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece | — | Psoriatic Arthritis | Unknown | 2019-04-15 | 2022-12-31 | ClinicalTrials.gov |
| NCT03958864 | A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001… | Phase1 | Healthy Volunteer | Completed | 2019-04-04 | 2019-06-13 | ClinicalTrials.gov |
| NCT03450343 | Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large… | Phase1 | Large B-Cell Diffuse Lymphoma | Completed | 2019-04-04 | 2024-01-30 | ClinicalTrials.gov |
| NCT03732703 | Myeloma-Developing Regimens Using Genomics (MyDRUG) | Phase1 | Relapsed Refractory Multiple Myeloma | Completed | 2019-04-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT03647124 | A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction … | — | Lymphoma, Mantle-Cell | Completed | 2019-03-13 | 2024-01-10 | ClinicalTrials.gov |
| NCT03850067 | A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in… | Phase1 | Small Cell Lung Carcinoma | Completed | 2019-03-12 | 2024-07-16 | ClinicalTrials.gov |
| NCT03809780 | Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone | Phase2 | Multiple Myeloma | Unknown | 2019-03-11 | 2025-12-31 | ClinicalTrials.gov |
| NCT05177393 | Treatment Outcomes of Esophageal Cancer | — | Esophageal Cancer | Recruiting | 2019-02-28 | 2027-06-30 | ClinicalTrials.gov |
| NCT03741933 | Apremilast and Moderate to Severe Chronic Hand Dermatitis | Phase4 | Chronic Hand Dermatitis | Withdrawn | 2019-02-28 | 2019-08-01 | ClinicalTrials.gov |
| NCT03824678 | Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Sev… | Phase1 | Hepatic Impairment | Completed | 2019-02-13 | 2019-06-18 | ClinicalTrials.gov |
| NCT03742921 | ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refracto… | — | Lymphoma, T-Cell, Peripheral | Completed | 2019-02-04 | 2023-10-31 | ClinicalTrials.gov |
| NCT03745430 | RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line… | Phase1 | Pancreatic Adenocarcinoma | Completed | 2019-01-29 | 2023-04-23 | ClinicalTrials.gov |
| NCT03655080 | Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After… | Phase2 | Cord Compression | Terminated | 2019-01-09 | 2021-06-15 | ClinicalTrials.gov |
| NCT03682536 | A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epo… | Phase3 | Myelodysplastic Syndromes | Active_Not_Recruiting | 2019-01-02 | 2027-09-28 | ClinicalTrials.gov |
| NCT04251078 | Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripher… | — | Myelodysplastic Syndromes | Recruiting | 2019-01-01 | 2025-06-30 | ClinicalTrials.gov |
| NCT04515732 | Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAP… | Phase4 | Psoriasis | Unknown | 2018-12-14 | 2021-10-01 | ClinicalTrials.gov |
| NCT03601078 | An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory… | Phase2 | Multiple Myeloma | Completed | 2018-12-13 | 2026-01-15 | ClinicalTrials.gov |
| NCT03742882 | A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moder… | Phase1 | Hepatic Impairment | Completed | 2018-12-06 | 2019-06-10 | ClinicalTrials.gov |
| NCT03593018 | Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Thera… | Phase3 | Relapsed Angioimmunoblastic T-Cell Lymphoma | Completed | 2018-11-09 | 2025-08-28 | ClinicalTrials.gov |
| NCT03575351 | A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Ad… | Phase3 | Lymphoma, Non-Hodgkin | Completed | 2018-10-23 | 2023-10-23 | ClinicalTrials.gov |
| NCT03567616 | A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Par… | Phase2 | Multiple Myeloma | Terminated | 2018-10-18 | 2020-06-18 | ClinicalTrials.gov |
| NCT03590652 | Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Re… | Phase2 | Relapsed/Refractory Multiple Myeloma | Terminated | 2018-10-17 | 2025-07-02 | ClinicalTrials.gov |
| NCT03743246 | A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects Wi… | Phase1 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Terminated | 2018-10-17 | 2024-01-26 | ClinicalTrials.gov |
| NCT03837132 | Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Can… | — | Advanced Cancer | Completed | 2018-10-15 | 2021-06-30 | ClinicalTrials.gov |
| NCT03690544 | Apremilast for RAS | Phase4 | Recurrent Aphthous Stomatitis | Completed | 2018-10-12 | 2021-07-14 | ClinicalTrials.gov |
| NCT03537222 | Quality of Life in Patients With Multiple Myeloma-validation Study | — | Multiple Myeloma | Terminated | 2018-10-10 | 2021-07-31 | ClinicalTrials.gov |
| NCT03720366 | A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients | Phase1 | Leukemia, Myeloid, Acute | Completed | 2018-10-04 | 2023-12-22 | ClinicalTrials.gov |
| NCT03579771 | Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High… | Phase2 | Resectable Cholangiocarcinoma | Completed | 2018-09-26 | 2023-09-16 | ClinicalTrials.gov |
| NCT03665610 | Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacoki… | — | Healthy Volunteers | Completed | 2018-09-10 | 2019-01-10 | ClinicalTrials.gov |
| NCT03701711 | Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study | Phase1 | Demyelinating Sensorimotor Neuropathy | Terminated | 2018-09-10 | 2022-02-28 | ClinicalTrials.gov |
| NCT02863458 | DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Ma… | — | Acute Myeloid Leukemia | Withdrawn | 2018-09-01 | 2020-09-30 | ClinicalTrials.gov |
| NCT03507491 | Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refra… | Phase1 | Cancer | Completed | 2018-08-27 | 2024-02-02 | ClinicalTrials.gov |
| NCT03467958 | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's D… | Phase3 | Crohn Disease | Terminated | 2018-08-24 | 2024-10-31 | ClinicalTrials.gov |
| NCT03392571 | Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cance… | Phase2 | Resectable Pancreatic Cancer | Withdrawn | 2018-08-15 | 2020-12-30 | ClinicalTrials.gov |
| NCT03345095 | A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblasto… | Phase3 | Newly Diagnosed Glioblastoma | Completed | 2018-07-26 | 2023-06-30 | ClinicalTrials.gov |
| NCT03971825 | A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Ps… | Phase1 | Healthy Volunteers | Terminated | 2018-07-24 | 2021-08-05 | ClinicalTrials.gov |
| NCT03694119 | Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on… | Phase1 | Healthy Volunteer | Completed | 2018-07-24 | 2019-01-08 | ClinicalTrials.gov |
| NCT03587194 | Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis | Phase4 | Psoriasis | Completed | 2018-07-23 | 2019-07-01 | ClinicalTrials.gov |
| NCT03602755 | A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant… | — | Multiple Myeloma | Completed | 2018-07-19 | 2019-01-18 | ClinicalTrials.gov |
| NCT03422640 | Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibros… | Phase4 | Frontal Fibrosing Alopecia | Unknown | 2018-07-12 | 2019-01-01 | ClinicalTrials.gov |
| NCT03644576 | Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Ef… | Phase1 | Healthy Volunteers | Completed | 2018-07-11 | 2018-09-12 | ClinicalTrials.gov |
| NCT03464097 | A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderate… | Phase3 | Crohn Disease | Terminated | 2018-06-27 | 2024-10-03 | ClinicalTrials.gov |
| NCT03624959 | Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and… | Phase1 | Healthy Volunteer | Completed | 2018-06-20 | 2018-08-10 | ClinicalTrials.gov |
| NCT03484702 | Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants Wit… | Phase2 | Lymphoma, Non-Hodgkin | Completed | 2018-06-05 | 2023-12-15 | ClinicalTrials.gov |
| NCT03542266 | CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma | Phase2 | Previously Untreated Peripheral T-cell Lymphoma | Completed | 2018-06-01 | 2022-07-25 | ClinicalTrials.gov |
| NCT03376672 | Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patie… | Phase2 | Multiple Myeloma | Active_Not_Recruiting | 2018-05-31 | 2027-12-31 | ClinicalTrials.gov |
| NCT03289299 | Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transpla… | Phase2 | Smoldering Multiple Myeloma | Active_Not_Recruiting | 2018-05-25 | 2031-11-15 | ClinicalTrials.gov |
| NCT03554993 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodyn… | Phase1 | Healthy Volunteer | Completed | 2018-05-23 | 2019-07-03 | ClinicalTrials.gov |
| NCT03493646 | Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or C… | Phase2 | Myelodysplastic Syndromes | Completed | 2018-05-18 | 2021-09-21 | ClinicalTrials.gov |
| NCT03521180 | A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celia… | — | Celiac Disease | Completed | 2018-05-11 | 2019-07-18 | ClinicalTrials.gov |
| NCT03486067 | Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With … | Phase1 | Multiple Myeloma | Terminated | 2018-04-03 | 2025-03-18 | ClinicalTrials.gov |
| NCT03289819 | Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclop… | Phase2 | Malignant Neoplasm of Breast | Completed | 2018-03-23 | 2021-01-22 | ClinicalTrials.gov |
| NCT03498625 | Crohn's Disease Endoscopic REmission Definition in an Objective Way | Na | CD | Completed | 2018-03-13 | 2021-12-31 | ClinicalTrials.gov |
| NCT03487900 | Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD P… | Na | CD | Unknown | 2018-03-13 | 2023-12-31 | ClinicalTrials.gov |
| NCT03440385 | Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Seve… | Phase3 | Crohn Disease | Completed | 2018-03-07 | 2023-11-21 | ClinicalTrials.gov |
| NCT03435341 | Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain | — | Leukemia, Myeloid, Acute | Completed | 2018-02-28 | 2020-04-30 | ClinicalTrials.gov |
| NCT03440372 | Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Seve… | Phase3 | Crohn Disease | Terminated | 2018-02-27 | 2024-10-01 | ClinicalTrials.gov |
| NCT03413800 | Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant | Phase2 | Relapsed Hematologic Malignancy | Active_Not_Recruiting | 2018-02-12 | 2026-01-01 | ClinicalTrials.gov |
| NCT03342404 | A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non… | Phase2 | Thalassemia | Completed | 2018-02-05 | 2022-11-28 | ClinicalTrials.gov |
| NCT02371590 | Lenalidomide and Obinutuzumab for Previously Untreated CLL | Phase2 | Chronic Lymphocytic Leukemia | Withdrawn | 2018-02-01 | 2022-12-01 | ClinicalTrials.gov |
| NCT03383575 | Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplasti… | Phase2 | Acute Myeloid Leukemia | Recruiting | 2018-01-17 | 2027-02-28 | ClinicalTrials.gov |
| NCT03337022 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics,… | Phase1 | Psoriasis | Completed | 2018-01-04 | 2019-04-26 | ClinicalTrials.gov |
| NCT03331640 | A Health Service Research Study to Investigate Survival of Metastatic Pancreati… | Phase2 | Metastatic Pancreatic Ductal Adenocarcinoma | Terminated | 2018-01-02 | 2021-09-13 | ClinicalTrials.gov |
| NCT03288974 | Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Tr… | — | Multiple Myeloma | Completed | 2017-12-28 | 2023-11-16 | ClinicalTrials.gov |
| NCT03310619 | A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/R… | Phase1 | Lymphoma, Non-Hodgkin | Completed | 2017-12-20 | 2023-02-15 | ClinicalTrials.gov |
| NCT03174275 | Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in … | Phase2 | Carcinoma, Squamous Cell | Active_Not_Recruiting | 2017-12-19 | 2027-02-02 | ClinicalTrials.gov |
| NCT03345810 | Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATI… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2017-12-14 | 2022-12-31 | ClinicalTrials.gov |
| NCT03361748 | Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Mu… | Phase2 | Multiple Myeloma | Completed | 2017-12-13 | 2023-12-20 | ClinicalTrials.gov |
| NCT02512497 | Romidepsin Maintenance After Allogeneic Stem Cell Transplantation | Phase1 | Cutaneous T-cell Lymphoma | Completed | 2017-12-08 | 2025-06-18 | ClinicalTrials.gov |
| NCT03324503 | A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocort… | Na | Sarcoidosis, Pulmonary | Completed | 2017-12-08 | 2019-11-15 | ClinicalTrials.gov |
| NCT03363815 | A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokin… | Phase1 | Heathy Volunteer | Completed | 2017-12-04 | 2018-07-29 | ClinicalTrials.gov |
| NCT03359460 | Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome | Phase1 | Myelodysplastic Syndrome | Completed | 2017-12-01 | 2019-11-17 | ClinicalTrials.gov |
| NCT02974322 | A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adu… | Phase3 | Crohn Disease | Withdrawn | 2017-12-01 | 2018-12-24 | ClinicalTrials.gov |
| NCT03239106 | A Study Examining the Medication Apremilast as Treatment for Chronic Itch | Phase2 | Itch | Completed | 2017-12-01 | 2019-09-19 | ClinicalTrials.gov |
| NCT03030261 | Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous … | Phase2 | Multiple Myeloma in Relapse | Active_Not_Recruiting | 2017-11-22 | 2027-09-26 | ClinicalTrials.gov |
| NCT03194542 | A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloprol… | Phase2 | Primary Myelofibrosis | Completed | 2017-11-15 | 2022-07-18 | ClinicalTrials.gov |
| NCT03340662 | Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction … | Phase1 | Healthy Volunteer | Completed | 2017-11-09 | 2018-01-27 | ClinicalTrials.gov |
| NCT03191539 | Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Ev… | Phase3 | Arthritis; Psoriasis (Etiology) | Unknown | 2017-11-02 | 2019-06-14 | ClinicalTrials.gov |
| NCT03270059 | Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the… | Phase2 | Central Nervous System Neoplasm | Recruiting | 2017-10-06 | 2028-12-15 | ClinicalTrials.gov |
| NCT03283202 | Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newl… | Phase1 | Diffuse B-Cell Lymphoma | Completed | 2017-10-04 | 2020-12-16 | ClinicalTrials.gov |
| NCT03241017 | Durvalumab in DLBCL After Autologous Transplant | Phase2 | Lymphoma, Large B-Cell, Diffuse | Withdrawn | 2017-10-01 | 2021-12-01 | ClinicalTrials.gov |
| NCT03188172 | MUK Nine b: OPTIMUM Treatment Protocol | Phase2 | Multiple Myeloma | Active_Not_Recruiting | 2017-09-28 | 2026-05-31 | ClinicalTrials.gov |
| NCT03283761 | FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastr… | Phase2 | Gastro-Esophageal Junction Adenocarcinoma | Completed | 2017-09-21 | 2023-01-16 | ClinicalTrials.gov |
| NCT03290443 | A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects Wit… | Phase1 | Hepatic Impairment | Completed | 2017-09-21 | 2018-10-26 | ClinicalTrials.gov |
| NCT03257631 | A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurren… | Phase2 | Central Nervous System Neoplasms | Completed | 2017-09-18 | 2023-09-14 | ClinicalTrials.gov |
| NCT03143049 | Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexametha… | Phase3 | Relapse Multiple Myeloma | Unknown | 2017-09-13 | 2022-06-01 | ClinicalTrials.gov |
| NCT03140943 | Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refr… | Phase2 | Relapsed and/or Refractory Multiple Myeloma | Unknown | 2017-09-13 | 2022-06-01 | ClinicalTrials.gov |
| NCT03294603 | Radiolabeled Study of CC-220 in Healthy Male Subjects | Phase1 | Healthy Volunteer | Completed | 2017-09-11 | 2017-10-16 | ClinicalTrials.gov |
| NCT03161483 | A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active S… | Phase2 | Lupus Erythematosus, Systemic | Completed | 2017-08-31 | 2021-08-03 | ClinicalTrials.gov |
| NCT03196401 | A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of S… | Phase1 | Solitary Bone Plasmacytoma | Withdrawn | 2017-07-27 | 2020-06-01 | ClinicalTrials.gov |
| NCT03142191 | A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopa… | Phase2 | Idiopathic Pulmonary Fibrosis | Terminated | 2017-07-26 | 2021-12-24 | ClinicalTrials.gov |
| NCT03220347 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Ef… | Phase1 | Lymphoma, Non-Hodgkin | Terminated | 2017-07-24 | 2024-09-06 | ClinicalTrials.gov |
| NCT03160248 | An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular … | Phase2 | Nummular Eczema | Completed | 2017-07-05 | 2021-09-15 | ClinicalTrials.gov |
| NCT03054532 | Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refra… | Phase2 | LYMPHOMA | Unknown | 2017-07-01 | 2021-07-01 | ClinicalTrials.gov |
| NCT03001804 | Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Prac… | — | Multiple Myeloma | Completed | 2017-06-30 | 2022-12-16 | ClinicalTrials.gov |
| NCT03015922 | Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma | Phase1 | Multiple Myeloma | Unknown | 2017-06-05 | 2021-10-01 | ClinicalTrials.gov |
| NCT03059485 | DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherap… | Phase2 | Acute Myelogenous Leukemia | Active_Not_Recruiting | 2017-06-01 | 2026-12-04 | ClinicalTrials.gov |
| NCT03098589 | Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) | — | Lymphoma | Completed | 2017-05-30 | 2020-09-18 | ClinicalTrials.gov |
| NCT03135509 | A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulat… | Phase1 | Healthy Volunteers | Completed | 2017-05-24 | 2017-06-28 | ClinicalTrials.gov |
| NCT03082729 | Vascular Inflammation in Psoriasis - Apremilast | Phase4 | Psoriasis | Completed | 2017-04-24 | 2021-08-17 | ClinicalTrials.gov |
| NCT03123016 | Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for… | Phase2 | Vitiligo | Completed | 2017-04-14 | 2019-08-05 | ClinicalTrials.gov |
| NCT03059953 | A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicA… | — | Moderate Plaque Psoriasis | Completed | 2017-04-07 | 2019-04-24 | ClinicalTrials.gov |
| NCT03097016 | A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderat… | Phase1 | Renal Insufficiency | Completed | 2017-03-30 | 2017-12-23 | ClinicalTrials.gov |
| NCT02963610 | Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumo… | Phase1 | Relapsed or Refractory Solid Tumors | Terminated | 2017-03-29 | 2018-03-20 | ClinicalTrials.gov |
| NCT03000452 | A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus… | Phase2 | Multiple Myeloma | Completed | 2017-03-14 | 2017-12-04 | ClinicalTrials.gov |
| NCT02733250 | Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer | Phase1 | Lung Cancer | Completed | 2017-03-13 | 2019-12-13 | ClinicalTrials.gov |
| NCT02886065 | A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smo… | Phase1 | Smoldering Multiple Myeloma | Active_Not_Recruiting | 2017-03-07 | 2026-09-15 | ClinicalTrials.gov |
| NCT03003520 | A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in… | Phase2 | Lymphoma, Large B-Cell, Diffuse | Completed | 2017-02-28 | 2022-04-24 | ClinicalTrials.gov |
| NCT03069326 | A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination… | Phase2 | Myelofibrosis | Active_Not_Recruiting | 2017-02-27 | 2027-02-01 | ClinicalTrials.gov |
| NCT02616965 | A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedot… | Phase1 | Cutaneous T-cell Lymphoma (CTCL) | Completed | 2017-02-22 | 2024-01-31 | ClinicalTrials.gov |
| NCT02992522 | Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed o… | Phase1 | B-Cell Lymphoma, Unspecified | Active_Not_Recruiting | 2017-02-21 | 2026-08-15 | ClinicalTrials.gov |
| NCT02816021 | Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) … | Phase2 | Melanoma and Other Malignant Neoplasms of Skin | Completed | 2017-02-14 | 2026-03-19 | ClinicalTrials.gov |
| NCT02682693 | Denosumab as an add-on Neoadjuvant Treatment (GeparX) | Phase2 | Breast Cancer Female NOS | Completed | 2017-02-13 | 2020-12-31 | ClinicalTrials.gov |
| NCT02977780 | INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) | Phase2 | Glioblastoma | Recruiting | 2017-02-09 | 2028-04-30 | ClinicalTrials.gov |
| NCT03049267 | Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppur… | Phase2 | Hidradenitis Suppurativa | Completed | 2017-02-02 | 2018-06-28 | ClinicalTrials.gov |
| NCT02371577 | Evaluation of the Immune Restoration Potential Of Lenalidomide | Phase2 | Chronic Lymphocytic Leukemia (CLL) | Withdrawn | 2017-02-01 | 2020-12-01 | ClinicalTrials.gov |
| NCT02985190 | A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic… | Phase2 | MDS | Completed | 2017-01-26 | 2022-08-30 | ClinicalTrials.gov |
| NCT02767557 | Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreat… | Phase2 | Unresectable Pancreatic Carcinoma | Completed | 2017-01-26 | 2023-01-01 | ClinicalTrials.gov |
| NCT02887248 | Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible … | Phase2 | Urothelial Carcinoma | Terminated | 2017-01-12 | 2020-05-01 | ClinicalTrials.gov |
| NCT03023527 | Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple… | Phase1 | Multiple Myeloma | Terminated | 2017-01-01 | 2018-01-01 | ClinicalTrials.gov |
| NCT02723331 | Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adeno… | Phase2 | Pancreatic Cancer | Completed | 2016-12-30 | 2022-12-28 | ClinicalTrials.gov |
| NCT03000309 | Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topi… | Phase4 | Plaque Psoriasis | Completed | 2016-12-29 | 2018-04-25 | ClinicalTrials.gov |
| NCT02946333 | A Study to Assess Disease Burden, in Terms of Health-related Quality of Life an… | — | Multiple Myeloma | Completed | 2016-12-25 | 2022-10-31 | ClinicalTrials.gov |
| NCT02973191 | A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subje… | Phase1 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Withdrawn | 2016-12-20 | 2021-01-24 | ClinicalTrials.gov |
| NCT02900560 | Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resista… | Phase2 | Epithelial Ovarian Cancer | Terminated | 2016-12-20 | 2021-05-27 | ClinicalTrials.gov |
| NCT04602273 | Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allog… | — | Myelodysplastic Syndromes | Unknown | 2016-12-12 | 2021-06-30 | ClinicalTrials.gov |
| NCT02967133 | A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer Metastatic | Terminated | 2016-12-01 | 2018-01-01 | ClinicalTrials.gov |
| NCT02564146 | First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Ge… | Phase2 | Metastatic Pancreatic Cancer | Completed | 2016-12-01 | 2022-05-01 | ClinicalTrials.gov |
| NCT02934269 | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-9… | Phase1 | Healthy Volunteers | Completed | 2016-11-21 | 2017-08-15 | ClinicalTrials.gov |
| NCT02848001 | A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute … | Phase1 | Leukemia, Myeloid, Acute | Terminated | 2016-11-14 | 2024-04-11 | ClinicalTrials.gov |
| NCT02871323 | Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-E… | Phase1 | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Withdrawn | 2016-11-01 | — | ClinicalTrials.gov |
| NCT02957474 | A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump… | Phase1 | Healthy Volunteers | Completed | 2016-11-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02916771 | Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smolderi… | Phase2 | Smoldering Multiple Myeloma | Completed | 2016-10-01 | 2025-01-08 | ClinicalTrials.gov |
| NCT02937571 | High Dose Carfilzomib for Newly Diagnosed Myeloma | Phase1 | Multiple Myeloma | Completed | 2016-10-01 | 2024-10-08 | ClinicalTrials.gov |
| NCT02935790 | Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab | Phase1 | Malignant Melanoma | Completed | 2016-09-30 | 2017-04-07 | ClinicalTrials.gov |
| NCT02769832 | Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer | Phase2 | Small Cell Lung Cancer (SCLC) | Completed | 2016-08-29 | 2022-07-07 | ClinicalTrials.gov |
| NCT02635061 | Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients Wit… | Phase1 | Non Small Cell Lung Cancer | Terminated | 2016-08-25 | 2024-01-22 | ClinicalTrials.gov |
| NCT02897830 | Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus… | Phase2 | Multiple Myeloma | Terminated | 2016-08-05 | 2020-08-31 | ClinicalTrials.gov |
| NCT02819882 | A Prospective Registry Study in Patients With Unresectable Locally Advanced or … | — | Breast Neoplasms | Recruiting | 2016-08-01 | 2026-06-01 | ClinicalTrials.gov |
| NCT02842229 | A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a… | — | Myelodysplastic Syndromes | Completed | 2016-07-20 | 2017-02-02 | ClinicalTrials.gov |
| NCT02632305 | A Study to See the Effects That a New Combination of the Three Drugs, Nab-pacli… | Phase2 | Unresectable Biliary Tract Cancer | Active_Not_Recruiting | 2016-07-13 | 2026-12-01 | ClinicalTrials.gov |
| NCT02807454 | A Study to Determine the Safety and Efficacy for the Combination of Durvalumab … | Phase2 | Multiple Myeloma | Terminated | 2016-07-07 | 2022-01-03 | ClinicalTrials.gov |
| NCT02833883 | Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-R… | Phase1 | Prostate Cancer | Completed | 2016-07-01 | 2023-01-13 | ClinicalTrials.gov |
| NCT02820935 | Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Inducti… | Phase1 | Pharmacokinetics | Completed | 2016-07-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT02797015 | Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS | Phase1 | Multiple Sclerosis | Completed | 2016-06-23 | 2017-10-20 | ClinicalTrials.gov |
| NCT02589145 | Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autol… | Phase1 | Lymphoma | Terminated | 2016-06-22 | 2019-04-08 | ClinicalTrials.gov |
| NCT02718833 | A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relap… | Phase2 | Multiple Myeloma | Active_Not_Recruiting | 2016-06-21 | 2027-12-01 | ClinicalTrials.gov |
| NCT02661815 | A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecologi… | Phase1 | Ovarian Cancer | Terminated | 2016-06-15 | 2017-07-28 | ClinicalTrials.gov |
| NCT02716038 | Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2016-06-07 | 2022-10-01 | ClinicalTrials.gov |
| NCT02775903 | An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Du… | Phase2 | Leukemia, Myeloid, Acute | Completed | 2016-06-03 | 2021-12-27 | ClinicalTrials.gov |
| NCT02677922 | A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Deh… | Phase1 | Leukemia, Myeloid, Acute | Active_Not_Recruiting | 2016-06-03 | 2026-09-30 | ClinicalTrials.gov |
| NCT02685059 | Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in T… | Phase2 | Breast Cancer | Completed | 2016-06-01 | 2018-03-01 | ClinicalTrials.gov |
| NCT04242849 | IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up | — | Acute Myeloid Leukemia | Completed | 2016-05-23 | 2020-01-16 | ClinicalTrials.gov |
| NCT02569320 | HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multip… | Phase1 | Recurrent Plasma Cell Myeloma | Completed | 2016-05-20 | 2021-03-10 | ClinicalTrials.gov |
| NCT02370888 | Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenou… | Phase1 | Leukemia, Myeloid | Terminated | 2016-05-16 | 2019-05-31 | ClinicalTrials.gov |
| NCT02733042 | A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy an… | Phase1 | Lymphoma | Completed | 2016-05-11 | 2022-08-21 | ClinicalTrials.gov |
| NCT02604433 | An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults… | Phase3 | Erythrocyte Transfusion | Completed | 2016-05-02 | 2021-01-05 | ClinicalTrials.gov |
| NCT02786511 | Longterm Follow-up of Subjects Treated With bb2121 | — | Multiple Myeloma | Completed | 2016-04-28 | 2019-10-11 | ClinicalTrials.gov |
| NCT02685826 | A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamet… | Phase1 | Multiple Myeloma | Completed | 2016-04-25 | 2022-09-06 | ClinicalTrials.gov |
| NCT02573493 | Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally… | Phase2 | Squamous Cell Carcinoma of the Head and Neck | Completed | 2016-04-13 | 2024-07-01 | ClinicalTrials.gov |
| NCT02685683 | Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn'… | Phase2 | Crohn's Disease | Terminated | 2016-04-04 | 2017-11-09 | ClinicalTrials.gov |
| NCT02705638 | Treatment of IgG4-Related Disease With Revlimid and Rituximab | Phase1 | Immunoglobulin G Subclass 4 Related Disease | Completed | 2016-04-01 | 2019-04-01 | ClinicalTrials.gov |
| NCT02654132 | An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethas… | Phase2 | Multiple Myeloma | Completed | 2016-03-18 | 2021-10-21 | ClinicalTrials.gov |
| NCT02548962 | Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjec… | Phase1 | Multiple Myeloma | Terminated | 2016-03-01 | 2018-06-13 | ClinicalTrials.gov |
| NCT02641002 | A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk… | Phase1 | Leukemia, Myeloid, Acute | Terminated | 2016-03-01 | 2018-07-18 | ClinicalTrials.gov |
| NCT02626689 | To Document the Burden of Illness on the Quality of Life and the Impact on Heal… | — | Beta-Thalassemia | Completed | 2016-03-01 | 2017-01-03 | ClinicalTrials.gov |
| NCT02024009 | Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | Phase1 | Pancreatic Neoplasms (Locally Advanced Non-metastatic) | Completed | 2016-03-01 | 2021-06-23 | ClinicalTrials.gov |
| NCT02512172 | A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer | Phase1 | Colorectal Cancer | Completed | 2016-02-19 | 2021-11-20 | ClinicalTrials.gov |
| NCT02631070 | A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Inte… | Phase3 | Myelodysplastic Syndromes | Completed | 2016-02-09 | 2020-11-26 | ClinicalTrials.gov |
| NCT02516696 | BiRd vs. Rd as Initial Therapy in Multiple Myeloma | Phase3 | Multiple Myeloma | Terminated | 2016-02-01 | 2022-07-22 | ClinicalTrials.gov |
| NCT02427841 | Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Befo… | Phase2 | Pancreatic Adenocarcinoma | Completed | 2016-01-21 | 2022-12-12 | ClinicalTrials.gov |
| NCT03307148 | Stromal TARgeting for PAncreatic Cancer (STAR_PAC) | Phase1 | Pancreatic Adenocarcinoma | Completed | 2016-01-15 | 2019-03-19 | ClinicalTrials.gov |
| NCT04369287 | Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myelo… | — | Acute Myeloid Leukemia | Unknown | 2016-01-01 | 2020-12-15 | ClinicalTrials.gov |
| NCT02722954 | A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metast… | Phase1 | Locally Advanced or Metastatic Solid Tumors | Completed | 2016-01-01 | 2017-05-19 | ClinicalTrials.gov |
| NCT02655159 | Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breas… | — | Breast Neoplasms | Terminated | 2016-01-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02632708 | Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidatio… | Phase1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | Active_Not_Recruiting | 2015-12-31 | 2026-07-24 | ClinicalTrials.gov |
| NCT02551185 | ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Completed | 2015-12-22 | 2019-10-04 | ClinicalTrials.gov |
| NCT02658929 | Study of bb2121 in Multiple Myeloma | Phase1 | Multiple Myeloma | Completed | 2015-12-22 | 2022-09-22 | ClinicalTrials.gov |
| NCT02601300 | An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ul… | Phase2 | Colitis, Ulcerative | Completed | 2015-12-14 | 2017-08-08 | ClinicalTrials.gov |
| NCT02633137 | Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide… | Phase2 | Mantle Cell Lymphoma | Completed | 2015-12-14 | 2023-11-07 | ClinicalTrials.gov |
| NCT02596893 | Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects… | Phase3 | Crohn Disease | Terminated | 2015-12-08 | 2018-01-05 | ClinicalTrials.gov |
| NCT02431559 | Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinu… | Phase1 | Ovarian Cancer | Completed | 2015-12-02 | 2021-06-10 | ClinicalTrials.gov |
| NCT02531126 | An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Coli… | Phase3 | Ulcerative Colitis | Completed | 2015-12-02 | 2024-12-19 | ClinicalTrials.gov |
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (No… | — | Metastatic Non-small Cell Lung Cancer (NSCLC) | Recruiting | 2015-12-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT02441686 | Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib … | Phase2 | Multiple Myeloma | Completed | 2015-12-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT02501902 | Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC | Phase1 | Metastatic Pancreatic Ductal Adenocarcinoma | Completed | 2015-11-23 | 2018-12-27 | ClinicalTrials.gov |
| NCT02529852 | A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large… | Phase1 | Lymphoma | Completed | 2015-11-04 | 2022-10-31 | ClinicalTrials.gov |
| NCT02494258 | A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects W… | Phase2 | Hematologic Neoplasm | Completed | 2015-10-22 | 2025-04-14 | ClinicalTrials.gov |
| NCT02576717 | A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple … | Phase3 | Multiple Sclerosis | Completed | 2015-10-16 | 2023-01-05 | ClinicalTrials.gov |
| NCT02392507 | A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Parti… | Phase2 | Carcinoma, Non-Small Cell Lung Cancer (NSCLC) | Completed | 2015-10-12 | 2019-11-06 | ClinicalTrials.gov |
| NCT02531113 | Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease | Phase2 | Crohn's Disease | Completed | 2015-10-09 | 2019-11-28 | ClinicalTrials.gov |
| NCT02670746 | A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in … | — | Pancreatic Neoplasms | Terminated | 2015-10-01 | 2017-11-28 | ClinicalTrials.gov |
| NCT02542657 | Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patien… | Phase1 | Myeloma | Active_Not_Recruiting | 2015-10-01 | 2025-12-01 | ClinicalTrials.gov |
| NCT02447666 | Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myel… | Phase2 | Myelodysplastic Syndrome | Completed | 2015-09-15 | 2019-05-24 | ClinicalTrials.gov |
| NCT02509039 | A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients Wi… | Phase1 | Lymphoma, Non-Hodgkin | Terminated | 2015-09-02 | 2023-05-09 | ClinicalTrials.gov |
| NCT02344472 | Detect V / CHEVENDO (Chemo vs. Endo) | Phase3 | Metastatic Breast Cancer | Active_Not_Recruiting | 2015-09-01 | 2025-01-31 | ClinicalTrials.gov |
| NCT02358161 | Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With… | Phase1 | Pancreatic Cancer | Completed | 2015-09-01 | 2019-01-01 | ClinicalTrials.gov |
| NCT02384083 | Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Rel… | Phase1 | Multiple Myeloma | Completed | 2015-09-01 | 2020-03-23 | ClinicalTrials.gov |
| NCT02521714 | Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Su… | Phase1 | Healthy Volunteers | Completed | 2015-08-14 | 2015-09-23 | ClinicalTrials.gov |
| NCT02450877 | A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and… | Phase2 | Leukemia, Myeloid, Acute | Completed | 2015-08-12 | 2019-10-08 | ClinicalTrials.gov |
| NCT02510937 | Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis | Phase1 | Pulmonary Fibrosis | Completed | 2015-08-05 | 2017-02-06 | ClinicalTrials.gov |
| NCT02525653 | Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or… | Phase2 | Lung Cancer | Completed | 2015-08-01 | 2019-05-01 | ClinicalTrials.gov |
| NCT02502188 | Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Sev… | Phase1 | Parapsoriasis | Terminated | 2015-07-17 | 2015-11-02 | ClinicalTrials.gov |
| NCT02393794 | Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple… | Phase1 | Triple-Negative Breast Cancer | Active_Not_Recruiting | 2015-07-17 | 2026-07-01 | ClinicalTrials.gov |
| NCT03141203 | Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refract… | Phase1 | Peripheral T Cell Lymphoma | Completed | 2015-07-13 | 2021-09-23 | ClinicalTrials.gov |
| NCT02281084 | Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes | Phase2 | Myelodysplastic Syndromes | Completed | 2015-07-06 | 2023-09-14 | ClinicalTrials.gov |
| NCT02047513 | Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for… | Phase2 | Resectable Pancreatic Cancer | Completed | 2015-07-01 | 2022-10-01 | ClinicalTrials.gov |
| NCT02391662 | Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancre… | Phase2 | Pancreatic Carcinoma Metastatic | Completed | 2015-06-23 | 2019-03-01 | ClinicalTrials.gov |
| NCT02435992 | Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis | Phase3 | Ulcerative Colitis | Completed | 2015-06-17 | 2020-06-17 | ClinicalTrials.gov |
| NCT02382406 | Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC | Phase1 | Non-Small Cell Lung Cancer | Terminated | 2015-06-04 | 2022-04-14 | ClinicalTrials.gov |
| NCT02486601 | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Opera… | Phase2 | Cancer of Stomach | Unknown | 2015-06-01 | 2022-06-01 | ClinicalTrials.gov |
| NCT02267707 | Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine … | Phase1 | Pancreatic Neoplasms | Terminated | 2015-05-27 | 2016-02-10 | ClinicalTrials.gov |
| NCT02417285 | A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With … | Phase1 | Lymphoma, Large B-Cell, Diffuse | Completed | 2015-05-22 | 2023-09-28 | ClinicalTrials.gov |
| NCT02443168 | Radiolabeled Study of AG-221 in Healthy Male Subjects. | Phase1 | Healthy Volunteers | Completed | 2015-05-14 | 2015-07-21 | ClinicalTrials.gov |
| NCT02400242 | Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone i… | Phase1 | Multiple Myeloma | Terminated | 2015-05-07 | 2024-06-03 | ClinicalTrials.gov |
| NCT02317991 | Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients W… | Phase2 | Gastroesophageal Cancer | Completed | 2015-05-05 | 2021-05-21 | ClinicalTrials.gov |
| NCT02472691 | Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Rel… | Phase2 | Leukemia, Myeloid, Acute | Completed | 2015-05-01 | 2020-04-23 | ClinicalTrials.gov |
| NCT02415413 | Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Mult… | Phase2 | Smoldering Multiple Myeloma | Active_Not_Recruiting | 2015-05-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT02921828 | A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patient… | — | Multiple Myeloma | Completed | 2015-04-30 | 2015-12-10 | ClinicalTrials.gov |
| NCT02343536 | A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects… | Phase1 | Lymphoma, Large B-Cell, Diffuse | Completed | 2015-04-29 | 2020-01-29 | ClinicalTrials.gov |
| NCT02289456 | Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Fol… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2015-04-28 | 2017-02-22 | ClinicalTrials.gov |
| NCT02289898 | Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus… | Phase2 | Pancreatic Cancer | Completed | 2015-04-20 | 2017-09-01 | ClinicalTrials.gov |
| NCT02330562 | Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; St… | Phase1 | Malignant Glioma | Completed | 2015-04-15 | 2021-06-02 | ClinicalTrials.gov |
| NCT02367183 | A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects… | Phase1 | Crohn Disease | Completed | 2015-04-08 | 2017-12-14 | ClinicalTrials.gov |
| NCT02341781 | Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who F… | — | Lymphoma, Mantle-Cell | Completed | 2015-04-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT02460276 | A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Ref… | Phase2 | Relapsed/Refractory Mantle Cell Lymphoma | Completed | 2015-04-01 | 2019-12-31 | ClinicalTrials.gov |
| NCT02902900 | An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine C… | — | Multiple Myeloma | Completed | 2015-04-01 | 2022-05-31 | ClinicalTrials.gov |
| NCT02405910 | Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squam… | Phase2 | Non-small Cell Lung Cancer | Withdrawn | 2015-03-15 | 2023-04-01 | ClinicalTrials.gov |
| NCT02374099 | Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of … | Phase2 | Breast Neoplasms | Terminated | 2015-03-13 | 2017-11-21 | ClinicalTrials.gov |
| NCT02367196 | A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and H… | Phase1 | Hematologic Neoplasms | Completed | 2015-03-12 | 2020-12-24 | ClinicalTrials.gov |
| NCT02280525 | Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma | Phase1 | Leukemia | Completed | 2015-03-05 | 2019-07-09 | ClinicalTrials.gov |
| NCT02387866 | PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Mal… | Phase1 | Healthy | Completed | 2015-03-02 | 2015-07-27 | ClinicalTrials.gov |
| NCT02555839 | Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in C… | — | Multiple Myeloma | Completed | 2015-02-20 | 2023-06-30 | ClinicalTrials.gov |
| NCT03807999 | Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment… | Phase2 | Pancreatic Neoplasm | Completed | 2015-02-19 | 2018-11-01 | ClinicalTrials.gov |
| NCT02285062 | Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Place… | Phase3 | Lymphoma, Large B-Cell, Diffuse | Completed | 2015-02-17 | 2022-07-28 | ClinicalTrials.gov |
| NCT02269943 | Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advan… | Phase2 | Nasopharyngeal Neoplasms | Completed | 2015-02-13 | 2017-04-20 | ClinicalTrials.gov |
| NCT02181218 | Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Pat… | Phase1 | Lymphoma, T-Cell, Cutaneous | Completed | 2015-02-04 | 2020-06-26 | ClinicalTrials.gov |
| NCT02270814 | Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable He… | Phase2 | Head and Neck Cancer | Active_Not_Recruiting | 2015-02-02 | 2026-06-30 | ClinicalTrials.gov |
| NCT02312102 | Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic… | Phase1 | Myelodysplastic Syndrome | Completed | 2015-02-01 | 2024-10-07 | ClinicalTrials.gov |
| NCT02259582 | A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus… | Phase2 | Nonsquamous Nonsmall Cell Neoplasm of Lung | Completed | 2015-02-01 | 2017-04-07 | ClinicalTrials.gov |
| NCT02309177 | Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Panc… | Phase1 | Breast Neoplasms | Completed | 2015-01-12 | 2018-09-12 | ClinicalTrials.gov |
| NCT02250326 | Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel Wit… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2015-01-07 | 2023-08-17 | ClinicalTrials.gov |
| NCT02313012 | Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors | Phase1 | Neoplasm Metastasis | Terminated | 2015-01-05 | 2016-05-03 | ClinicalTrials.gov |
| NCT02255162 | Lenalidomide in Combination With Microtransplantation as Post-remission Therapy… | Phase1 | Acute Myeloid Leukemia (AML) | Terminated | 2015-01-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02279654 | Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of T… | — | Myelodysplastic Syndrome | Completed | 2014-12-17 | 2022-03-29 | ClinicalTrials.gov |
| NCT02279394 | E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Ri… | Phase2 | Smoldering Myeloma | Completed | 2014-12-11 | 2022-01-26 | ClinicalTrials.gov |
| NCT02342847 | Observational Study of Quality of Live in Patients With Metastatic Pancreatic C… | — | Pancreatic Neoplasms | Completed | 2014-12-10 | 2018-11-16 | ClinicalTrials.gov |
| NCT02181634 | Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Pa… | Phase2 | Cholangiocarcinoma | Completed | 2014-12-09 | 2017-10-01 | ClinicalTrials.gov |
| NCT02273739 | Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid … | Phase1 | Solid Tumor | Completed | 2014-12-08 | 2016-06-03 | ClinicalTrials.gov |
| NCT02347904 | Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients Wi… | Phase1 | Esophageal Cancer | Completed | 2014-12-01 | 2019-11-01 | ClinicalTrials.gov |
| NCT02328105 | LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer | Phase2 | Lung Cancer | Completed | 2014-12-01 | 2019-12-06 | ClinicalTrials.gov |
| NCT01924169 | Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia … | Phase2 | Hematologic Disorder | Terminated | 2014-11-24 | 2017-02-21 | ClinicalTrials.gov |
| NCT02321644 | Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Ef… | Phase1 | Healthy Subjects | Completed | 2014-11-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02406144 | Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus… | Phase3 | Multiple Myeloma | Completed | 2014-11-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT02192489 | A Phase 2 Study With CC-220 in Skin Sarcoidosis | Phase2 | Sarcoidosis | Withdrawn | 2014-11-01 | 2017-06-30 | ClinicalTrials.gov |
| NCT02158702 | Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who H… | Phase2 | Multiple Myeloma | Unknown | 2014-11-01 | 2018-11-01 | ClinicalTrials.gov |
| NCT02125136 | Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced P… | Phase2 | Ductal Adenocarcinoma of the Pancreas | Completed | 2014-11-01 | 2020-02-19 | ClinicalTrials.gov |
| NCT02124850 | A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus … | Phase1 | Squamous Cell Carcinoma of the Head and Neck | Terminated | 2014-10-28 | 2016-10-31 | ClinicalTrials.gov |
| NCT02223052 | Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic … | Phase1 | Hematological Neoplasms | Completed | 2014-10-27 | 2018-12-18 | ClinicalTrials.gov |
| NCT02273713 | The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasiz… | Phase1 | Esophageal Cancer | Completed | 2014-10-01 | 2017-03-01 | ClinicalTrials.gov |
| NCT02230917 | A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Mul… | Phase2 | Multiple Myeloma | Withdrawn | 2014-10-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02234999 | Radiolabeled Study of CC-122 in Healthy Subjects | Phase1 | Healthy Volunteers | Completed | 2014-09-23 | 2014-10-08 | ClinicalTrials.gov |
| NCT02086604 | Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B… | Phase1 | Lymphoma, Large B-Cell, Diffuse | Completed | 2014-09-18 | 2022-01-12 | ClinicalTrials.gov |
| NCT02185040 | A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. | Phase2 | Systemic Lupus Erythematosus | Completed | 2014-09-16 | 2018-09-25 | ClinicalTrials.gov |
| NCT02189343 | Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidom… | Phase1 | Multiple Myeloma | Completed | 2014-09-15 | 2018-04-30 | ClinicalTrials.gov |
| NCT02098473 | Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis | Phase2 | Eosinophilic Esophagitis | Completed | 2014-08-31 | 2017-01-30 | ClinicalTrials.gov |
| NCT02218346 | Food Effect Study of AG-221 in Healthy Male Subjects | Phase1 | Healthy Volunteers | Completed | 2014-08-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02188368 | Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patie… | Phase2 | Multiple Myeloma | Terminated | 2014-07-07 | 2020-10-23 | ClinicalTrials.gov |
| NCT02124369 | Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) | Phase2 | Pancreatic Adenocarcinoma | Terminated | 2014-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02155634 | Continuous Lenalidomide Therapy Versus Observation Following Induction Without … | Phase3 | Multiple Myeloma | Withdrawn | 2014-07-01 | 2021-03-01 | ClinicalTrials.gov |
| NCT02164955 | A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relap… | — | Multiple Myeloma | Completed | 2014-06-26 | 2022-10-10 | ClinicalTrials.gov |
| NCT02151149 | Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat … | Phase4 | Non-Small Cell Lung Cancer | Completed | 2014-06-09 | 2017-07-14 | ClinicalTrials.gov |
| NCT02066454 | Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Pa… | Phase3 | Myeloma | Completed | 2014-06-05 | 2016-07-12 | ClinicalTrials.gov |
| NCT02103335 | Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Rel… | Phase1 | Multiple Myeloma in Relapse | Completed | 2014-06-05 | 2016-11-30 | ClinicalTrials.gov |
| NCT02018523 | Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer | Phase1 | Carcinoma, Non-Small-Cell Lung | Terminated | 2014-06-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02176213 | Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory M… | Phase2 | Multiple Myeloma in Relapse | Completed | 2014-06-01 | 2019-05-07 | ClinicalTrials.gov |
| NCT02168205 | Food Effect and CYP1A2 Induction Study in Healthy Subjects | Phase1 | Healthy Volunteers | Completed | 2014-05-30 | 2014-09-19 | ClinicalTrials.gov |
| NCT02433457 | Relative Bioavailability Study of CC-292 | Phase1 | Healthy Volunteers | Completed | 2014-05-26 | 2014-09-26 | ClinicalTrials.gov |
| NCT02103062 | Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer | Phase2 | Colorectal Neoplasms | Completed | 2014-05-05 | 2015-01-09 | ClinicalTrials.gov |
| NCT02141828 | A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatmen… | Phase1 | Leukemia | Completed | 2014-05-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02142049 | Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed… | Phase1 | Diffuse Large B Cell Lymphoma Relapsed | Completed | 2014-05-01 | 2017-08-01 | ClinicalTrials.gov |
| NCT02112175 | Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velc… | Phase3 | Multiple Myeloma | Completed | 2014-04-30 | 2020-10-12 | ClinicalTrials.gov |
| NCT02244125 | A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide an… | Phase2 | Multiple Myeloma | Completed | 2014-04-14 | 2023-05-29 | ClinicalTrials.gov |
| NCT02106884 | Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated Wit… | Phase2 | Pancreatic Cancer | Completed | 2014-04-01 | 2019-04-29 | ClinicalTrials.gov |
| NCT01938833 | Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breas… | Phase1 | HER2-negative Breast Cancer | Terminated | 2014-04-01 | 2016-12-08 | ClinicalTrials.gov |
| NCT01996865 | Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenan… | Phase3 | Lymphoma, Non-Hodgkin | Completed | 2014-04-01 | 2024-09-17 | ClinicalTrials.gov |
| NCT01964430 | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Pat… | Phase3 | Pancreatic Neoplasms | Completed | 2014-03-28 | 2022-06-30 | ClinicalTrials.gov |
| NCT02077166 | Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With R… | Phase1 | Relapsed Diffuse Large B-Cell Lymphoma | Completed | 2014-03-13 | 2020-12-17 | ClinicalTrials.gov |
| NCT02403869 | Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monoc… | — | Breast Neoplasms | Completed | 2014-03-12 | 2019-01-31 | ClinicalTrials.gov |
| NCT02033993 | Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or Af… | Phase2 | Urothelial Cancer | Completed | 2014-03-11 | 2020-10-28 | ClinicalTrials.gov |
| NCT01902225 | Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combinat… | Phase1 | Lymphoma | Completed | 2014-03-04 | 2020-04-11 | ClinicalTrials.gov |
| NCT01997840 | ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Re… | Phase1 | Multiple Myeloma | Terminated | 2014-03-01 | 2024-02-29 | ClinicalTrials.gov |
| NCT02092116 | Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduc… | Phase1 | HIV I Infection | Completed | 2014-03-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02076243 | Treatment With Nab-paclitaxel in Cutaneous SCC | Phase2 | Cutaneous Squamous Cell Carcinoma | Terminated | 2014-03-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02075021 | Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitax… | Phase1 | Relapsed or Refractory Multiple Myeloma | Terminated | 2014-03-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01816620 | Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagno… | Phase2 | POEMS Syndrome | Completed | 2014-03-01 | 2017-04-01 | ClinicalTrials.gov |
| NCT02045017 | Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Ren… | Phase2 | Multiple Myeloma | Completed | 2014-02-28 | 2021-07-28 | ClinicalTrials.gov |
| NCT02405364 | Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction | Phase2 | Multiple Myeloma | Completed | 2014-02-01 | 2019-11-25 | ClinicalTrials.gov |
| NCT02110420 | First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of … | Phase1 | Healthy Volunteers | Completed | 2014-02-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02073487 | Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Per… | Phase2 | Breast Cancer | Completed | 2014-02-01 | 2019-01-01 | ClinicalTrials.gov |
| NCT02030483 | Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Mye… | Phase1 | Multiple Myeloma | Terminated | 2014-02-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02004275 | Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients Wi… | Phase1 | Multiple Myeloma in Relapse | Unknown | 2014-02-01 | — | ClinicalTrials.gov |
| NCT02021500 | A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pa… | — | Pancreatic Cancer | Completed | 2014-01-02 | 2015-04-16 | ClinicalTrials.gov |
| NCT01807286 | Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloid… | Phase1 | Myeloma | Terminated | 2014-01-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01927718 | Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic … | Na | Myeloma | Terminated | 2014-01-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT01933061 | Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab… | Phase2 | Metastatic Melanoma | Withdrawn | 2014-01-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT03529175 | Scheduling Nab-paclitaxel With Gemcitabine | Phase2 | Pancreatic Adenocarcinoma Metastatic | Completed | 2014-01-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02017015 | Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patient… | Phase2 | Pancreatic Neoplasms | Completed | 2013-12-24 | 2016-08-03 | ClinicalTrials.gov |
| NCT01964534 | Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patien… | Phase2 | Metastatic Pancreatic Cancer | Unknown | 2013-12-12 | 2017-07-01 | ClinicalTrials.gov |
| NCT01688011 | Connect® Myeloid Disease Registry | — | Primary Myelofibrosis | Terminated | 2013-12-12 | 2024-10-18 | ClinicalTrials.gov |
| NCT02414100 | Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients … | — | Pancreatic Ductal Adenocarcinoma | Withdrawn | 2013-12-12 | 2016-12-15 | ClinicalTrials.gov |
| NCT02047734 | Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis | Phase3 | Relapsing Multiple Sclerosis | Completed | 2013-12-03 | 2017-04-13 | ClinicalTrials.gov |
| NCT01985477 | Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractor… | Phase1 | Myeloma | Terminated | 2013-12-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02017457 | Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell… | Phase2 | Acute Myelogenous Leukemia | Completed | 2013-12-01 | 2019-11-01 | ClinicalTrials.gov |
| NCT02011113 | Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in S… | Phase2 | Multiple Myeloma | Completed | 2013-12-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01999582 | A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) … | Phase2 | Anemia | Completed | 2013-11-30 | 2016-08-31 | ClinicalTrials.gov |
| NCT01938001 | Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent No… | Phase3 | Lymphoma, Non-Hodgkin | Completed | 2013-11-21 | 2022-01-26 | ClinicalTrials.gov |
| NCT01754857 | Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lena… | Phase2 | Lymphoid Leukemia | Completed | 2013-11-12 | 2022-06-30 | ClinicalTrials.gov |
| NCT01937442 | Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma | Phase1 | Multiple Myeloma | Completed | 2013-11-07 | 2015-09-23 | ClinicalTrials.gov |
| NCT01928576 | Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. | Phase2 | Non-Small Cell Lung Cancer | Completed | 2013-11-06 | 2023-04-04 | ClinicalTrials.gov |
| NCT01754870 | Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Follo… | Phase2 | Chronic Lymphocytic Leukemia (CLL) | Withdrawn | 2013-11-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01998035 | Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies | Phase1 | Lymphoid Malignancies | Terminated | 2013-11-01 | 2020-01-06 | ClinicalTrials.gov |
| NCT01979276 | Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma | Phase1 | Multiple Myeloma | Terminated | 2013-11-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT01947309 | Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalid… | — | Multiple Myeloma | Terminated | 2013-11-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01835587 | Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogene… | Phase1 | Leukemia, Myeloid, Acute | Completed | 2013-10-25 | 2017-05-26 | ClinicalTrials.gov |
| NCT01986894 | A Phase 1 QT Study in Healthy Male Subjects | Phase1 | Clinical Pharmacology, Healthy Volunteer Study | Completed | 2013-10-18 | 2013-12-02 | ClinicalTrials.gov |
| NCT01838434 | Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or R… | Phase1 | Relapsed/Refractory Mantle Cell Lymphoma | Completed | 2013-10-17 | 2017-05-01 | ClinicalTrials.gov |
| NCT01836029 | Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recur… | Phase2 | Carcinoma, Squamous Cell of Head and Neck | Completed | 2013-10-14 | 2016-09-19 | ClinicalTrials.gov |
| NCT01846390 | Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Periph… | Phase1 | Peripheral T-Cell Lymphoma | Completed | 2013-10-01 | 2018-09-19 | ClinicalTrials.gov |
| NCT01975610 | Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrex… | Phase2 | Rheumatoid Arthritis | Completed | 2013-10-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01702831 | Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) an… | Phase2 | Multiple Myeloma | Completed | 2013-10-01 | 2022-07-31 | ClinicalTrials.gov |
| NCT01881230 | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Car… | Phase2 | Breast Tumor | Completed | 2013-09-26 | 2016-10-28 | ClinicalTrials.gov |
| NCT01916252 | Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in … | Phase3 | Multiple Myeloma | Completed | 2013-09-01 | 2016-11-16 | ClinicalTrials.gov |
| NCT02060656 | Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse … | Phase2 | Diffuse Large B-Cell Lymphoma | Unknown | 2013-09-01 | 2023-08-01 | ClinicalTrials.gov |
| NCT01915498 | Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Mali… | Phase1 | Hematologic Neoplasms | Completed | 2013-08-27 | 2023-10-31 | ClinicalTrials.gov |
| NCT01896323 | CC-223 and Ketoconazole Drug-Drug Interaction Study | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01913119 | A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymp… | Early_Phase1 | Histologically Proven Extranodal NKTcell Lymphoma | Completed | 2013-07-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01908387 | Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms | Phase1 | Myelodysplastic Syndromes | Terminated | 2013-07-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01829568 | Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Unt… | Phase1 | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma | Active_Not_Recruiting | 2013-06-26 | 2027-06-06 | ClinicalTrials.gov |
| NCT01702844 | Single Arm on the Tolerability of Weekly Nab-paclitaxel | Phase2 | Non Small Cell Lung Cancer (NSCLC) | Completed | 2013-06-25 | 2019-07-12 | ClinicalTrials.gov |
| NCT01874223 | Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in… | — | Interstitial Lung Disease | Completed | 2013-06-01 | 2018-11-04 | ClinicalTrials.gov |
| NCT02394210 | Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma | — | Multiple Myeloma | Terminated | 2013-05-14 | 2021-05-18 | ClinicalTrials.gov |
| NCT02034773 | 3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynam… | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01827111 | Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma | Phase2 | Melanoma | Completed | 2013-04-25 | 2020-09-21 | ClinicalTrials.gov |
| NCT01729104 | Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Rela… | Phase1 | Lymphoma | Terminated | 2013-04-25 | 2018-10-03 | ClinicalTrials.gov |
| NCT01757288 | Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidatio… | Phase1 | STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER | Completed | 2013-03-25 | 2019-06-03 | ClinicalTrials.gov |
| NCT01715142 | Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-pacli… | Early_Phase1 | Pancreatic Adenocarcinoma Resectable | Completed | 2013-03-21 | 2017-04-30 | ClinicalTrials.gov |
| NCT01794169 | Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly P… | Phase2 | Acute Myeloid Leukemia | Terminated | 2013-03-01 | 2018-03-01 | ClinicalTrials.gov |
| NCT01835561 | Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired Males | Phase1 | Clinical Pharmacology, Healthy Volunteer Study | Completed | 2013-03-01 | 2014-08-21 | ClinicalTrials.gov |
| NCT01766583 | A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patien… | Phase1 | Relapsed/Refractory B-cell Lymphoma | Completed | 2013-02-01 | 2018-01-01 | ClinicalTrials.gov |
| NCT01734928 | Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in S… | Phase3 | Multiple Myeloma | Completed | 2013-01-07 | 2022-05-13 | ClinicalTrials.gov |
| NCT01754402 | Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma | Phase1 | Multiple Myeloma | Unknown | 2013-01-07 | 2025-01-01 | ClinicalTrials.gov |
| NCT01790737 | First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple… | Phase2 | Multiple Myeloma | Completed | 2013-01-01 | 2019-02-26 | ClinicalTrials.gov |
| NCT01788189 | Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas | Phase1 | B-cell Lymphoma | Completed | 2013-01-01 | 2020-02-20 | ClinicalTrials.gov |
| NCT01732861 | Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Le… | Phase1 | Leukemia Lymphocytic Chronic B-Cell | Completed | 2012-12-28 | 2019-01-23 | ClinicalTrials.gov |
| NCT02085798 | Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic My… | — | Myelodysplastic Syndrome | Completed | 2012-12-17 | 2018-12-14 | ClinicalTrials.gov |
| NCT01542918 | Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lympho… | Phase1 | Recurrent/Refractory CNS | Completed | 2012-12-17 | 2016-08-30 | ClinicalTrials.gov |
| NCT01743859 | Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute My… | Phase2 | Acute Myeloid Leukemia | Completed | 2012-12-06 | 2016-08-03 | ClinicalTrials.gov |
| NCT01620190 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients Wit… | Phase2 | Recurrent Non-Small Cell Lung Carcinoma | Completed | 2012-12-02 | 2019-04-29 | ClinicalTrials.gov |
| NCT01745588 | Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus… | Phase2 | Multiple Myeloma | Completed | 2012-12-01 | 2025-09-03 | ClinicalTrials.gov |
| NCT01755975 | Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refracto… | Phase1 | Multiple Myeloma | Completed | 2012-12-01 | 2023-10-01 | ClinicalTrials.gov |
| NCT01744626 | Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leuke… | Phase1 | Leukemia Lymphocytic Chronic B-Cell | Completed | 2012-12-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01712789 | Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dos… | Phase3 | Multiple Myeloma | Completed | 2012-11-06 | 2019-12-11 | ClinicalTrials.gov |
| NCT01730586 | Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas | Phase2 | Colorectal Cancer | Completed | 2012-11-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT01733875 | 2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & … | Phase1 | Healthy | Completed | 2012-11-01 | 2013-10-09 | ClinicalTrials.gov |
| NCT01571635 | Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adul… | Phase2 | Beta Thalassemia Major | Terminated | 2012-10-10 | 2022-05-24 | ClinicalTrials.gov |
| NCT01698801 | A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients W… | Phase2 | Multiple Myeloma | Completed | 2012-10-01 | 2018-06-26 | ClinicalTrials.gov |
| NCT01712828 | Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy… | Phase1 | Healthy | Completed | 2012-10-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01628393 | Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis… | Phase2 | Relapsing Multiple Sclerosis | Completed | 2012-09-18 | 2016-05-11 | ClinicalTrials.gov |
| NCT02348528 | Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chines… | Phase2 | Multiple Myeloma | Completed | 2012-09-11 | 2016-09-29 | ClinicalTrials.gov |
| NCT01617226 | Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients … | Phase2 | Leukemia, Myeloid, Acute | Completed | 2012-09-01 | 2020-12-01 | ClinicalTrials.gov |
| NCT01690702 | Study of Nab-Paclitaxel in High Risk Early Breast Cancer | Phase3 | Breast Cancer | Completed | 2012-09-01 | 2020-07-20 | ClinicalTrials.gov |
| NCT01707407 | A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition… | Phase1 | Pharmacology, Clinical | Completed | 2012-09-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01684150 | A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusio… | Phase1 | Acute Myeloid Leukemia | Completed | 2012-09-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01704781 | Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antir… | Phase1 | HIV-1 Infection | Completed | 2012-09-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01675141 | Lenalidomide Maintenance Therapy for Multiple Myeloma | Phase2 | Multiple Myeloma | Terminated | 2012-08-20 | 2017-03-10 | ClinicalTrials.gov |
| NCT01559129 | Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinet… | Phase2 | Scleroderma, Systemic | Terminated | 2012-08-09 | 2016-11-03 | ClinicalTrials.gov |
| NCT01433965 | Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myel… | Phase1 | Acute Myeloid Leukemia | Completed | 2012-08-08 | 2021-01-12 | ClinicalTrials.gov |
| NCT01460498 | Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (C… | Phase1 | Leukemia | Completed | 2012-08-08 | 2019-08-07 | ClinicalTrials.gov |
| NCT01638533 | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or… | Phase1 | Glioma | Completed | 2012-08-03 | 2020-09-01 | ClinicalTrials.gov |
| NCT01692184 | Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect … | Phase1 | Healthy | Completed | 2012-08-01 | 2012-10-08 | ClinicalTrials.gov |
| NCT01615042 | Phase I Study of Lenalidomide in Patients With Acute Leukemia | Phase1 | Acute Leukemia | Terminated | 2012-08-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT01599325 | Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients … | Phase2 | Myelodysplastic Syndrome (MDS) | Completed | 2012-07-24 | 2018-03-13 | ClinicalTrials.gov |
| NCT01556776 | A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following F… | Phase3 | Chronic Lymphocytic Leukemia | Completed | 2012-07-20 | 2021-01-14 | ClinicalTrials.gov |
| NCT01583283 | Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multip… | Phase1 | Multiple Myeloma | Completed | 2012-07-12 | 2021-03-24 | ClinicalTrials.gov |
| NCT01583426 | Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvan… | Phase3 | Tubular Breast Cancer Stage II | Completed | 2012-07-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT01639898 | POEMS Syndrome Treatment With Lenalidomide | Phase2 | POEMS Syndrome | Completed | 2012-07-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT01578954 | Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age Wit… | Phase1 | Acute Myeloid Leukemia | Completed | 2012-06-28 | 2016-05-18 | ClinicalTrials.gov |
| NCT01629082 | Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes an… | Phase1 | Myeldysplastic Syndrome (MDS) | Completed | 2012-06-06 | 2018-06-27 | ClinicalTrials.gov |
| NCT01570387 | A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previousl… | Phase1 | AL Amyloidosis | Completed | 2012-06-01 | 2019-04-01 | ClinicalTrials.gov |
| NCT01611467 | A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 a… | Phase1 | Safety and Pharmacokinetics in Healthy Volunteer Subjects | Completed | 2012-06-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01779167 | Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Mac… | Phase2 | Waldenstrom Macroglobulinemia | Terminated | 2012-06-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01575925 | Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients … | Phase1 | Multiple Myeloma | Completed | 2012-06-01 | 2018-08-07 | ClinicalTrials.gov |
| NCT01545947 | Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erl… | Phase1 | Carcinoma, Non-Small-Cell Lung | Completed | 2012-05-01 | 2014-12-11 | ClinicalTrials.gov |
| NCT02891551 | An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Pa… | — | Myelodysplastic Syndromes | Completed | 2012-05-01 | 2018-12-30 | ClinicalTrials.gov |
| NCT01685814 | Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, … | Phase3 | Previously Untreated Symptomatic Multiple Myeloma | Unknown | 2012-05-01 | 2023-12-01 | ClinicalTrials.gov |
| NCT01429025 | Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients Wi… | Phase1 | Refractory/Relapsed Indolent Non-Hodgkin Lymphoma | Completed | 2012-05-01 | 2019-07-01 | ClinicalTrials.gov |
| NCT01358734 | A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of… | Phase2 | Acute Myeloid Leukemia | Completed | 2012-04-27 | 2018-05-15 | ClinicalTrials.gov |
| NCT01565499 | Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Lu… | Phase2 | Breast Cancer | Completed | 2012-04-17 | 2018-05-27 | ClinicalTrials.gov |
| NCT00820768 | A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignan… | Phase1 | Solid Tumor | Withdrawn | 2012-04-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01568294 | Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Poma… | Phase1 | Multiple Myeloma | Completed | 2012-04-01 | 2015-07-08 | ClinicalTrials.gov |
| NCT01571648 | A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azaci… | Phase1 | Myelodysplastic Syndromes | Completed | 2012-04-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01125176 | Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Init… | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2012-03-30 | 2020-12-29 | ClinicalTrials.gov |
| NCT01496976 | Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolida… | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2012-03-30 | 2024-09-11 | ClinicalTrials.gov |
| NCT01465230 | Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Inductio… | Phase2 | Chronic Lymphocytic Leukemia | Terminated | 2012-03-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01652781 | 5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome | Phase2 | Myelodysplastic Syndrome | Unknown | 2012-03-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01701076 | Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Ther… | Phase2 | Multiple Myeloma | Completed | 2012-03-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01723839 | Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab … | Phase2 | Chronic Lymphocytic Leukemia (CLL) | Completed | 2012-02-22 | 2021-06-08 | ClinicalTrials.gov |
| NCT01497093 | Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomi… | Phase1 | Multiple Myeloma | Completed | 2012-02-15 | 2019-07-23 | ClinicalTrials.gov |
| NCT01519011 | Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Az… | Phase1 | Myelodysplastic Syndromes | Completed | 2012-02-07 | 2015-05-12 | ClinicalTrials.gov |
| NCT01537744 | A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid … | Phase1 | Solid Tumors | Completed | 2012-02-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01412229 | Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head… | Phase2 | Head and Neck Cancer | Completed | 2012-02-01 | 2019-12-01 | ClinicalTrials.gov |
| NCT01650701 | A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rit… | Phase3 | Follicular Lymphoma | Completed | 2012-02-01 | 2024-04-30 | ClinicalTrials.gov |
| NCT01541332 | Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Re… | Phase1 | Multiple Myeloma | Unknown | 2012-02-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01497496 | Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refracto… | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2012-01-26 | 2020-03-20 | ClinicalTrials.gov |
| NCT01518465 | Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With … | Phase2 | Stage I Multiple Myeloma | Terminated | 2012-01-09 | 2017-10-31 | ClinicalTrials.gov |
| NCT01349569 | Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Ne… | Phase2 | Multiple Myeloma | Completed | 2012-01-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT01373229 | Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (C… | Phase1 | Leukemia, Lymphocytic, Chronic, B-Cell | Completed | 2012-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01745640 | Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17… | Phase2 | Multiple Myeloma | Completed | 2012-01-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01476787 | Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Folli… | Phase3 | Follicular Lymphoma | Completed | 2011-12-29 | 2024-04-30 | ClinicalTrials.gov |
| NCT01446133 | Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small… | Phase2 | Leukemia | Active_Not_Recruiting | 2011-12-12 | 2028-06-30 | ClinicalTrials.gov |
| NCT01373294 | Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer | Phase2 | Bladder Cancer | Completed | 2011-11-30 | 2018-12-10 | ClinicalTrials.gov |
| NCT01432600 | Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophospham… | Phase1 | Myeloma | Completed | 2011-11-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT01466725 | A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid … | Phase2 | Discoid Lupus | Terminated | 2011-11-01 | 2012-07-30 | ClinicalTrials.gov |
| NCT01464034 | A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone … | Phase1 | Multiple Myeloma | Terminated | 2011-11-01 | 2020-07-01 | ClinicalTrials.gov |
| NCT01600053 | Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia | Phase2 | Chronic Lymphocytic Leukemia | Terminated | 2011-11-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01460940 | A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or … | Phase2 | Adult Lymphocyte Depletion Hodgkin Lymphoma | Completed | 2011-10-13 | 2016-11-16 | ClinicalTrials.gov |
| NCT01282047 | Lenalidomide in Kaposi Disease Associated With HIV Infection | Phase2 | HIV Infection Associated Kaposi Disease | Terminated | 2011-10-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01177735 | Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myel… | Phase2 | Multiple Myeloma | Completed | 2011-10-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01421524 | Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Pat… | Phase1 | Multiple Myeloma | Completed | 2011-09-12 | 2023-11-21 | ClinicalTrials.gov |
| NCT01207102 | Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative … | Phase2 | Metastatic Breast Cancer | Terminated | 2011-08-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01352338 | Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT) | Phase1 | Multiple Myeloma | Completed | 2011-08-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01355705 | Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relaps… | Phase1 | Multiple Myeloma | Completed | 2011-08-01 | 2017-07-01 | ClinicalTrials.gov |
| NCT01442714 | Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & H… | Phase2 | Leukemia | Terminated | 2011-08-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01474330 | A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharm… | Phase1 | Healthy | Completed | 2011-08-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01472562 | Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma | Phase2 | Mantle Cell Lymphoma | Completed | 2011-07-29 | 2023-07-30 | ClinicalTrials.gov |
| NCT01402284 | Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients | Phase2 | Multiple Myeloma | Completed | 2011-07-21 | 2020-09-24 | ClinicalTrials.gov |
| NCT01351935 | Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgki… | Phase1 | B Cell Non-Hodgkin's Lymphoma | Completed | 2011-07-18 | 2015-06-26 | ClinicalTrials.gov |
| NCT01323751 | Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in… | Phase1 | Multiple Myeloma | Completed | 2011-07-01 | 2016-12-03 | ClinicalTrials.gov |
| NCT01319422 | Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Ref… | Phase2 | Multiple Myeloma | Completed | 2011-06-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01386346 | Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectab… | Phase1 | Esophageal Cancer | Completed | 2011-06-01 | 2018-09-01 | ClinicalTrials.gov |
| NCT01364727 | A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies | Phase2 | Thymoma | Completed | 2011-06-01 | 2018-12-31 | ClinicalTrials.gov |
| NCT01484626 | Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myel… | Phase1 | Multiple Myeloma | Terminated | 2011-05-05 | 2014-06-18 | ClinicalTrials.gov |
| NCT02528838 | An Observational Study to Assess Safety and Outcome of the Various Medication U… | — | Multiple Myeloma | Completed | 2011-05-01 | 2018-01-15 | ClinicalTrials.gov |
| NCT01348503 | Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of… | Phase1 | Hepatocellular Carcinoma | Terminated | 2011-05-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01353664 | A Rollover Study for Patients Who Participated in Other Romidepsin Protocols | Phase2 | Lymphoma | Completed | 2011-05-01 | 2012-09-05 | ClinicalTrials.gov |
| NCT01298011 | Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Canc… | Phase2 | Resectable Pancreatic Cancer | Completed | 2011-05-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01207921 | Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lympho… | Phase1 | Hodgkin Disease | Completed | 2011-04-28 | 2021-03-05 | ClinicalTrials.gov |
| NCT01324323 | Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Ad… | Phase1 | Hematologic Malignancy | Completed | 2011-04-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01350947 | A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leuk… | Phase2 | Chronic Myelomonocytic Leukemia | Completed | 2011-04-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01324310 | Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients Wit… | Phase1 | Hematologic Malignancy | Completed | 2011-04-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01311687 | A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy an… | Phase3 | Multiple Myeloma | Completed | 2011-03-11 | 2017-08-29 | ClinicalTrials.gov |
| NCT02556905 | A Study to Collect and Evaluate the Safety and Efficacy Information of Korean M… | — | Multiple Myeloma | Completed | 2011-03-09 | 2016-11-30 | ClinicalTrials.gov |
| NCT02921815 | A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndro… | — | Myelodysplastic Syndromes | Completed | 2011-03-03 | 2014-08-31 | ClinicalTrials.gov |
| NCT01163071 | A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas | Phase1 | Advanced Solid Tumors | Terminated | 2011-03-01 | 2011-09-23 | ClinicalTrials.gov |
| NCT01310114 | Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effec… | Phase2 | Stroke, Acute | Terminated | 2011-03-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01202877 | PKC412 and 5-Azacytidine | Phase1 | Leukemia | Completed | 2011-03-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02922543 | A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapse… | — | Multiple Myeloma | Completed | 2011-02-18 | 2014-10-11 | ClinicalTrials.gov |
| NCT01246622 | Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Ac… | Phase1 | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Completed | 2011-02-07 | 2019-06-05 | ClinicalTrials.gov |
| NCT01303965 | Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk… | Phase1 | Multiple Myeloma | Terminated | 2011-02-07 | 2017-07-28 | ClinicalTrials.gov |
| NCT01331824 | Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic … | Phase2 | Bladder Cancer | Terminated | 2011-02-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01558167 | A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Len… | Phase1 | Chronic Lymphocytic Leukemia | Completed | 2011-02-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01237249 | Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 … | Phase2 | Multiple Myeloma | Completed | 2011-02-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01752075 | A Non-interventional, Observational Post-marketing Registry of Patients Treated… | — | Multiple Myeloma | Completed | 2011-01-01 | 2013-07-19 | ClinicalTrials.gov |
| NCT01203943 | A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idi… | Phase2 | Idiopathic Pulmonary Fibrosis | Terminated | 2011-01-01 | 2012-08-24 | ClinicalTrials.gov |
| NCT01254890 | Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome | Phase1 | Leukemia | Completed | 2011-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01401322 | Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymp… | Phase2 | Leukemia | Terminated | 2011-01-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01347944 | MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodyspla… | — | Myelodysplastic Syndrome | Completed | 2011-01-01 | 2013-06-30 | ClinicalTrials.gov |
| NCT01301820 | Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Com… | Phase2 | Acute Myeloid Leukemia | Completed | 2011-01-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT02340936 | Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and R… | Phase1 | Diffuse Large B-cell Lymphoma | Completed | 2011-01-01 | 2019-02-20 | ClinicalTrials.gov |
| NCT01379274 | A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes | Phase2 | MDS | Terminated | 2011-01-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01274533 | Lenalidomide in HTLV-1 Adult T-Cell Leukemia | Phase2 | Adult T Cell Leukemia/Lymphoma | Completed | 2010-12-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01261403 | Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effec… | Phase2 | Rheumatoid Arthritis | Terminated | 2010-12-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01488565 | A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Ac… | Phase2 | Myelodysplastic Syndromes (MDS) | Completed | 2010-12-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01316523 | Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-H… | Phase2 | Non Hodgkin's Lymphoma | Terminated | 2010-12-01 | 2024-04-14 | ClinicalTrials.gov |
| NCT02983097 | Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dex… | Phase1 | Diffuse Large B-cell Lymphoma (DLBCL) | Terminated | 2010-11-01 | 2015-04-28 | ClinicalTrials.gov |
| NCT01036087 | Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Brea… | Phase2 | Breast Cancer | Completed | 2010-11-01 | 2022-08-09 | ClinicalTrials.gov |
| NCT01191060 | Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With A… | Phase3 | Myeloma | Completed | 2010-10-01 | 2018-11-30 | ClinicalTrials.gov |
| NCT01241734 | Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Po… | Phase1 | Diffuse Large B Cell Lymphoma | Completed | 2010-10-01 | 2015-09-22 | ClinicalTrials.gov |
| NCT01201811 | Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplast… | Phase4 | Myelodysplastic Syndromes | Completed | 2010-10-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01088815 | Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas | Phase2 | Metastatic Pancreatic Cancer | Completed | 2010-09-17 | 2018-02-17 | ClinicalTrials.gov |
| NCT01218555 | Study of Everolimus (RAD001) in Combination With Lenalidomide | Phase1 | Solid Organ Malignancies | Completed | 2010-09-09 | 2020-11-05 | ClinicalTrials.gov |
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatm… | Phase3 | Multiple Myeloma | Active_Not_Recruiting | 2010-09-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT01202890 | Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant O… | Phase1 | Ovarian Cancer | Terminated | 2010-09-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01204138 | Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibi… | Phase2 | Arthritis, Rheumatoid | Withdrawn | 2010-09-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01120834 | Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed… | Phase1 | Lymphoma | Completed | 2010-09-01 | 2016-10-20 | ClinicalTrials.gov |
| NCT01142232 | Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplan… | Phase1 | Multiple Myeloma | Completed | 2010-08-27 | 2019-05-18 | ClinicalTrials.gov |
| NCT01183663 | Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Flu… | Phase1 | Advanced Cancers | Completed | 2010-08-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01180569 | Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma | Phase1 | Lymphoma | Withdrawn | 2010-08-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01155362 | PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease | Phase2 | Crohn's Disease | Completed | 2010-08-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01200472 | Efficacy Study of Apremilast (CC-10004) in Subjects With Erosive Hand Osteoarth… | Phase2 | Erosive Osteoarthritis of the Hand | Completed | 2010-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01199575 | Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Ly… | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2010-08-01 | 2022-07-19 | ClinicalTrials.gov |
| NCT01193517 | Azacitidine and CAPOX in Metastatic Colorectal Cancer | Phase1 | Colorectal Cancer | Completed | 2010-08-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT01054196 | Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell T… | Phase1 | Multiple Myeloma | Active_Not_Recruiting | 2010-08-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT01159574 | Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma | Phase2 | Multiple Myeloma | Completed | 2010-08-01 | 2015-05-05 | ClinicalTrials.gov |
| NCT01380106 | Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone fo… | Phase2 | Multiple Myeloma | Completed | 2010-08-01 | 2017-09-11 | ClinicalTrials.gov |
| NCT01177397 | Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patie… | Phase1 | Multiple Myeloma | Completed | 2010-07-20 | 2016-12-09 | ClinicalTrials.gov |
| NCT02921802 | A Study of Special Use Results Surveillance of Revlimid 5mg Capsules | — | Multiple Myeloma | Completed | 2010-07-20 | 2013-03-29 | ClinicalTrials.gov |
| NCT01167816 | Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancr… | Phase1 | Pancreatic Cancer | Terminated | 2010-07-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01005979 | A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Tr… | Phase1 | Leukemia, Lymphocytic, Chronic, B-Cell | Terminated | 2010-07-01 | — | ClinicalTrials.gov |
| NCT01161186 | Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreati… | Phase1 | Pancreatic Neoplasms | Completed | 2010-07-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01241786 | Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidi… | Phase2 | Chronic Lymphocytic Leukemia(CLL) | Terminated | 2010-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01169298 | A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety … | Phase1 | Adult T-cell Leukemia-Lymphoma | Completed | 2010-07-01 | 2013-12-20 | ClinicalTrials.gov |
| NCT01146574 | A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerabili… | Phase2 | Anemia | Completed | 2010-06-30 | 2016-03-07 | ClinicalTrials.gov |
| NCT01368757 | Lenalidomide in Patients With Chronic Myelomonocytic Leukemia | Phase1 | Chronic Myelomonocytic Leukemia | Unknown | 2010-06-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01074047 | Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute My… | Phase3 | Acute Myeloid Leukemia | Completed | 2010-06-01 | 2016-07-25 | ClinicalTrials.gov |
| NCT01045551 | Open Label Pilot Study of Apremilast in Treatment of Rosacea | Phase2 | Erythematotelangiectatic Rosacea | Completed | 2010-06-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01078974 | Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia | Phase1 | Waldenstrom's Macroglobulinemia | Terminated | 2010-05-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01123356 | Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rit… | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2010-05-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01133743 | Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the … | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2010-05-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01554852 | Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the… | Phase3 | Multiple Myeloma | Unknown | 2010-05-01 | 2022-12-01 | ClinicalTrials.gov |
| NCT01132989 | Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Ref… | Phase2 | Cutaneous T Cell Lymphoma | Unknown | 2010-05-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01129180 | Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-C… | Phase1 | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Completed | 2010-05-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01127542 | RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL… | Phase2 | Chronic Lymphocytic Leukaemia | Terminated | 2010-05-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01133275 | Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non… | Phase2 | Myelodysplastic Syndrome | Completed | 2010-04-28 | 2019-11-21 | ClinicalTrials.gov |
| NCT01135199 | Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis | Phase2 | Pulmonary Fibrosis | Withdrawn | 2010-04-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01016600 | Azacitidine and Lenalidomide for Acute Myeloid Leukemia | Phase1 | Leukemia, Myeloid, Acute | Completed | 2010-04-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01121757 | Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Z… | Phase2 | Follicular Lymphoma | Terminated | 2010-04-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01021423 | A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After C… | Phase3 | Mantle Cell Lymphoma | Terminated | 2010-04-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00997581 | Apremilast Therapy for Acute Gouty Arthritis | Phase2 | Acute Gout | Withdrawn | 2010-04-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01083706 | Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chroni… | Phase2 | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Completed | 2010-04-01 | — | ClinicalTrials.gov |
| NCT01060384 | Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractor… | Phase1 | Non-Hodgkin's Lymphoma | Completed | 2010-03-29 | 2018-01-01 | ClinicalTrials.gov |
| NCT01081015 | Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry | — | Chronic Lymphocytic Leukemia | Completed | 2010-03-19 | 2017-12-31 | ClinicalTrials.gov |
| NCT01166035 | Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors | Phase1 | Solid Tumors | Unknown | 2010-03-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01099267 | Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celge… | — | Myelodysplastic Syndrome | Completed | 2010-03-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01133665 | Cetuximab and Lenalidomide in Head and Neck | Phase2 | Squamous Cell Carcinoma | Completed | 2010-02-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01041625 | Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lic… | Phase2 | Lichen Planus | Unknown | 2010-02-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01029262 | A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent A… | Phase3 | Anemia | Completed | 2010-01-26 | 2018-05-09 | ClinicalTrials.gov |
| NCT01038388 | A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamet… | Phase1 | Multiple Myeloma | Completed | 2010-01-15 | 2021-08-05 | ClinicalTrials.gov |
| NCT01116193 | Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients W… | Phase2 | Leukemia, Lymphoid | Completed | 2010-01-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01649791 | Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stag… | Na | B-cell Chronic Lymphocytic Leukemia | Terminated | 2010-01-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01050790 | Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple M… | Na | Multiple Myeloma | Completed | 2010-01-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01243476 | Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelo… | Phase3 | Myelodysplastic Syndrome | Completed | 2010-01-01 | 2022-06-06 | ClinicalTrials.gov |
| NCT01004991 | Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma | Phase1 | Diffuse Large B Cell Lymphoma | Completed | 2010-01-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01032291 | A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With C… | Phase2 | Colorectal Cancer | Terminated | 2009-12-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01038635 | 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Synd… | Phase1 | Leukemia | Completed | 2009-12-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01076504 | A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extens… | Phase2 | Extensive-Stage Small Cell Lung Cancer | Completed | 2009-12-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT00988208 | Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With … | Phase3 | Prostate Cancer | Completed | 2009-11-11 | 2016-11-28 | ClinicalTrials.gov |
| NCT01011894 | Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years … | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2009-11-06 | 2016-02-23 | ClinicalTrials.gov |
| NCT01155505 | Lenalidomide and Paclitaxel in Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Unknown | 2009-11-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00889421 | Apremilast in the Treatment of Uveitis | Phase1 | Uveitis | Terminated | 2009-11-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01034592 | Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion… | Phase1 | Anemia | Terminated | 2009-11-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01096394 | Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian E… | — | Ovarian Cancer | Completed | 2009-11-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT00910910 | Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As Firs… | Phase3 | B-Cell Chronic Lymphocytic Leukemia | Completed | 2009-10-13 | 2018-05-09 | ClinicalTrials.gov |
| NCT00974233 | Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance … | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2009-10-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT00995488 | Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treat… | Phase2 | Urothelial Cancer | Terminated | 2009-10-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01547260 | Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreati… | Phase1 | Pancreatic Carcinoma Metastatic | Completed | 2009-10-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT00948064 | Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acu… | Phase2 | Leukemia | Completed | 2009-09-08 | 2017-08-03 | ClinicalTrials.gov |
| NCT00975806 | Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and … | Phase1 | Renal Cell Carcinoma | Terminated | 2009-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01081028 | Connect® MM- The Multiple Myeloma Disease Registry | — | Multiple Myeloma | Terminated | 2009-09-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT01002703 | Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With… | Phase1 | Multiple Myeloma | Unknown | 2009-09-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01029054 | Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed,… | Phase1 | Multiple Myeloma | Completed | 2009-09-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01160484 | Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for… | Phase2 | Multiple Myeloma | Completed | 2009-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00972842 | Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral… | Phase1 | Peripheral T-Cell Non-Hodgkin's Lymphoma | Terminated | 2009-09-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00963534 | Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Ove… | Phase1 | Mantle Cell Lymphoma | Completed | 2009-09-01 | 2017-08-01 | ClinicalTrials.gov |
| NCT00933426 | Lenalidomide and Paclitaxel in Prostate Cancer | Phase1 | Prostate Cancer | Terminated | 2009-08-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01206205 | Frontline Therapy in de Novo Multiple Myeloma Patients Under 65 | Phase2 | Multiple Myeloma | Completed | 2009-08-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00944658 | Spondylitis Trial of Apremilast for Better Rheumatic Therapy | Phase2 | Ankylosing Spondylitis | Completed | 2009-08-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00946270 | Pomalidomide for Myelofibrosis Patients | Phase2 | Polycythemia Vera | Completed | 2009-07-22 | 2018-05-22 | ClinicalTrials.gov |
| NCT00915252 | Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients… | Phase2 | Acute Myeloid Leukemia | Completed | 2009-07-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00944047 | Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast … | Phase2 | Breast Cancer | Completed | 2009-07-01 | 2017-08-01 | ClinicalTrials.gov |
| NCT00831766 | Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndr… | Phase1 | Myelodysplastic Syndrome | Completed | 2009-06-25 | 2020-11-16 | ClinicalTrials.gov |
| NCT00915083 | A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects o… | Phase1 | Advanced Solid Tumors | Completed | 2009-06-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00934440 | A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advan… | Phase1 | Renal Cell Carcinoma | Terminated | 2009-06-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT00931242 | Study of Apremilast in Atopic or Contact Dermatitis | Phase2 | Atopic Dermatitis | Completed | 2009-06-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00925821 | Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Tra… | Phase2 | Multiple Myeloma | Completed | 2009-06-01 | — | ClinicalTrials.gov |
| NCT00923234 | Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS… | Phase1 | Myelodysplastic Syndromes | Terminated | 2009-06-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01178814 | Revlimid in Transfusion Dependent Patients | Phase2 | Myelodysplastic Syndrome | Completed | 2009-06-01 | 2022-12-07 | ClinicalTrials.gov |
| NCT00899431 | Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CL… | Phase2 | Chronic Lymphocytic Leukemia | Terminated | 2009-05-06 | 2018-10-07 | ClinicalTrials.gov |
| NCT00901069 | Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lym… | Phase1 | Lymphoma | Completed | 2009-05-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01393158 | Apremilast for Atopic Dermatitis - A Pilot Study in Adults | Phase2 | Atopic Dermatitis | Completed | 2009-05-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00875667 | A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice … | Phase2 | Mantle Cell Lymphoma | Completed | 2009-04-30 | 2018-10-09 | ClinicalTrials.gov |
| NCT00928486 | A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Pati… | Phase3 | Multiple Myeloma | Completed | 2009-04-28 | 2010-09-10 | ClinicalTrials.gov |
| NCT00864253 | A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Met… | Phase3 | Malignant Melanoma | Completed | 2009-04-23 | 2014-02-12 | ClinicalTrials.gov |
| NCT00887068 | Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myeloge… | Phase3 | Leukemia | Completed | 2009-04-21 | 2018-08-20 | ClinicalTrials.gov |
| NCT00890929 | Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patien… | Phase1 | Acute Myeloid Leukemia (AML) | Completed | 2009-04-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00890552 | A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis | Na | Leukemia | Completed | 2009-04-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01185262 | Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based T… | Phase1 | Chronic Lymphocytic Leukemia | Completed | 2009-04-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT00698776 | Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With K… | Phase1 | Myeloma | Completed | 2009-04-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00903630 | Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithe… | Phase1 | Fallopian Tube Cancer | Terminated | 2009-04-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00828802 | Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes | Phase1 | Myelodysplastic Syndromes | Completed | 2009-03-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT02302469 | Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia | Phase1 | Waldenstrom Macroglobulinemia | Completed | 2009-03-01 | 2017-04-01 | ClinicalTrials.gov |
| NCT01553357 | Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia | Phase2 | Primary Plasma Cell Leukemia | Completed | 2009-03-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00890955 | Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies | Phase1 | Lung Cancer | Completed | 2009-03-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00844649 | Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Ge… | Phase3 | Metastatic Pancreatic Cancer | Completed | 2009-03-01 | 2013-04-09 | ClinicalTrials.gov |
| NCT01127386 | Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cach… | Phase1 | Cancer Cachexia Syndrome | Completed | 2009-03-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00799513 | Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B… | Phase2 | Diffuse Large B-cell Lymphoma | Completed | 2009-03-01 | 2021-08-01 | ClinicalTrials.gov |
| NCT00840931 | Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplast… | Phase1 | Leukemia | Completed | 2009-02-02 | 2019-12-01 | ClinicalTrials.gov |
| NCT00842582 | Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer | Phase1 | Ovarian Cancer | Withdrawn | 2009-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01015352 | Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System… | Phase2 | Myelodysplastic Syndromes | Completed | 2009-02-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT00885508 | A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses… | Phase2 | Myelodysplastic Syndrome | Unknown | 2009-02-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT00864942 | Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukem… | Phase1 | Chronic Lymphocytic Leukemia | Completed | 2009-02-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00847639 | Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-r… | Phase2 | Multiple Myeloma | Completed | 2009-02-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT00837031 | Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of t… | Phase2 | Metastatic Pancreatic Cancer | Completed | 2009-02-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00833807 | Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanom… | Phase1 | Melanoma | Completed | 2009-02-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT00495547 | SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelody… | Phase2 | Myelodysplastic Syndrome | Terminated | 2009-02-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00774345 | A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Ther… | Phase3 | B-cell Chronic Lymphocytic Leukemia | Completed | 2009-01-27 | 2020-10-27 | ClinicalTrials.gov |
| NCT00829647 | A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia | Phase1 | Chronic Lymphocytic Leukemia | Withdrawn | 2009-01-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT00360672 | Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndro… | Phase2 | Acute Myelogenous Leukemia | Completed | 2009-01-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT00736944 | Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-F… | Phase2 | Squamous Cell Carcinoma of the Head and Neck | Completed | 2008-12-19 | 2020-07-06 | ClinicalTrials.gov |
| NCT00813124 | Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelo… | Phase2 | Stem Cell Transplantation | Completed | 2008-12-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT00840827 | Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patie… | Phase2 | Myelodysplastic Syndrome | Terminated | 2008-12-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00814632 | CC-10004 For The Treatment Of Vulvodynia | Phase2 | Vulvodynia | Completed | 2008-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00583349 | Intravesicular Abraxane for Treatment-Refractory Bladder Cancer | Phase1 | Bladder Cancer | Completed | 2008-12-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00688415 | Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer | Phase1 | Advanced Solid Tumors | Completed | 2008-11-07 | 2010-11-01 | ClinicalTrials.gov |
| NCT00876070 | Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in … | — | Metastatic Breast Cancer | Completed | 2008-11-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00843310 | Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment fo… | Phase2 | Multiple Myeloma | Terminated | 2008-11-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00652626 | Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Wi… | Phase1 | MDS | Completed | 2008-11-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00794274 | The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis | Phase2 | Sarcoidosis | Completed | 2008-11-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00777673 | Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be… | Phase2 | Breast Cancer | Unknown | 2008-10-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00738829 | Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated C… | Phase1 | Leukemia, Lymphocytic, Chronic, B-Cell | Completed | 2008-10-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01090128 | Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, D… | Phase1 | Stages II-III Breast Cancer | Terminated | 2008-09-01 | 2017-03-24 | ClinicalTrials.gov |
| NCT00869089 | Safety and Efficacy of CC-10004 for Prurigo Nodularis | Phase2 | Prurigo Nodularis | Completed | 2008-09-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00759603 | Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2008-09-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT00748553 | A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/M… | Phase1 | Advanced or Metastatic Solid Tumors | Completed | 2008-09-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT00848328 | Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma | Phase2 | Lymphoma | Terminated | 2008-08-25 | 2024-04-15 | ClinicalTrials.gov |
| NCT00729612 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treat… | Phase2 | Lung Cancer | Completed | 2008-08-14 | 2011-12-16 | ClinicalTrials.gov |
| NCT00761722 | Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With M… | Phase1 | Acute Myeloid Leukemia | Completed | 2008-08-12 | 2016-04-07 | ClinicalTrials.gov |
| NCT00691704 | Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Ther… | Phase2 | Multiple Myeloma | Completed | 2008-08-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT00736619 | Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Ra… | Phase1 | HEAD & NECK Cancer | Completed | 2008-08-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT00717522 | Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tiss… | Phase2 | Soft Tissue Sarcoma | Terminated | 2008-08-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00738361 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients Wit… | Phase2 | Intraocular Melanoma | Completed | 2008-08-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT00699842 | A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low… | Phase1 | Myelodysplastic Syndrome | Terminated | 2008-07-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT00731380 | A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradio… | Phase1 | Head and Neck Cancer | Completed | 2008-07-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT00675259 | Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With … | Phase2 | Breast Cancer | Completed | 2008-07-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT00721214 | 5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodyspla… | Phase2 | Myelodysplastic Syndrome | Completed | 2008-07-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT00701311 | An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syn… | Phase2 | Prostatitis | Completed | 2008-06-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00833833 | MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexa… | Phase1 | Multiple Myeloma | Completed | 2008-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00633594 | Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma | Phase1 | Mantle Cell Lymphoma | Completed | 2008-06-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT00957385 | Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients | Phase2 | Acute Myeloid Leukemia | Completed | 2008-06-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT00708916 | Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhi… | Phase1 | Discoid Lupus Erythematosus | Completed | 2008-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00684242 | Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain | Phase2 | Advanced Cancer | Terminated | 2008-05-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00671801 | Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Mult… | Phase1 | Malignant Gliomas | Terminated | 2008-04-29 | 2014-02-01 | ClinicalTrials.gov |
| NCT00629499 | Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Bre… | Phase2 | Breast Cancer | Completed | 2008-04-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00720850 | Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MD… | Phase2 | Myelodysplastic Syndromes | Terminated | 2008-04-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00675441 | Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-… | Phase2 | Graft-versus-Host Disease | Terminated | 2008-04-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00665652 | Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal … | Phase2 | Neuropathy | Terminated | 2008-04-01 | 2011-05-19 | ClinicalTrials.gov |
| NCT00642759 | Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Ad… | Phase2 | Non-small Cell Lung Cancer | Completed | 2008-04-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT00624936 | Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acu… | Phase1 | Leukemia | Completed | 2008-04-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT00683059 | Single Agent Abraxane as Second Line Therapy in Bladder Cancer | Phase2 | Transitional Cell Carcinoma | Completed | 2008-03-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00660400 | Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrom… | Na | Leukemia | Completed | 2008-03-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT00903942 | Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) | Phase2 | Non-small Cell Lung Cancer, Stage III | Withdrawn | 2008-03-01 | — | ClinicalTrials.gov |
| NCT00655668 | A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refr… | Phase2 | T-cell Non-Hodgkin's Lymphoma | Terminated | 2008-03-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00667147 | Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib | Phase1 | Solid Tumors | Completed | 2008-03-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT00667082 | NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic… | Phase1 | Non-Small Cell Lung Cancer | Completed | 2008-03-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00607581 | Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated P… | Phase2 | Amyloidosis | Completed | 2008-02-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01222195 | Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome … | Phase2 | Leukemia | Terminated | 2008-02-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00654186 | Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-… | Phase2 | Prostate Cancer | Completed | 2008-02-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00632359 | Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disea… | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2008-02-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT00860457 | Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocy… | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2008-02-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00537511 | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of … | Phase1 | Carcinoma, Small Cell | Terminated | 2008-02-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00628238 | Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chro… | Phase2 | Chronic Lymphocytic Leukemia | Unknown | 2008-02-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00456846 | First Line Therapy for Patients With Metastatic Breast Cancer | Phase2 | Metastatic Breast Cancer | Terminated | 2008-02-01 | 2013-05-31 | ClinicalTrials.gov |
| NCT00518284 | Prevention of Restenosis Following Revascularization | Phase2 | Vascular Disease, Peripheral | Terminated | 2008-01-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT01848028 | PsoBest - The German Psoriasis Registry | — | Psoriasis | Recruiting | 2008-01-01 | 2032-12-01 | ClinicalTrials.gov |
| NCT00744536 | Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to… | Phase2 | Myelodysplastic Syndromes | Completed | 2008-01-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00536341 | Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patient… | Phase1 | Chronic Lymphocytic Leukemia | Completed | 2008-01-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT00617591 | Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Ne… | Phase2 | Multiple Myeloma | Completed | 2008-01-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT00585689 | Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Ca… | Phase2 | Bladder Cancer | Completed | 2007-12-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT00635284 | ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies | Phase1 | Solid Tumors | Completed | 2007-12-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00580242 | A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide … | Phase1 | Myelodysplasia | Completed | 2007-11-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00531271 | ABI-008 Trial in Patients With Metastatic Breast Cancer | Phase1 | Metastatic Breast Cancer | Terminated | 2007-11-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00633945 | Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus E… | Na | Cutaneous Lupus Erythematosus (CLE) | Completed | 2007-11-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00540514 | Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lu… | Phase3 | Non-Small Cell Lung Carcinoma | Completed | 2007-11-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT00540579 | CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas | Phase1 | Pancreatic Cancer | Completed | 2007-11-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00570674 | Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced… | Phase1 | Squamous Cell Carcinoma of the Head and Neck | Terminated | 2007-11-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00535873 | Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia… | Phase2 | Leukemia | Completed | 2007-10-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT00609869 | Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Rela… | Phase2 | Lymphocytic Leukemia | Completed | 2007-10-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00654836 | Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recu… | Phase2 | Breast Cancer | Completed | 2007-10-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00543114 | Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL | Phase1 | Chronic Lymphocytic Leukemia | Terminated | 2007-10-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00540644 | Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients … | Phase2 | Multiple Myeloma | Completed | 2007-10-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT00629343 | Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide | Phase1 | Soft Tissue Sarcoma | Completed | 2007-10-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00528983 | Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects … | Phase1 | Myelodysplastic Syndromes (MDS) | Completed | 2007-09-11 | 2016-04-05 | ClinicalTrials.gov |
| NCT00540007 | Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma | Phase2 | Hodgkin Disease | Completed | 2007-09-06 | 2016-09-01 | ClinicalTrials.gov |
| NCT00607438 | A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally… | Phase2 | Breast Cancer | Terminated | 2007-09-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00812968 | Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Jap… | Phase2 | Myelodysplastic Syndromes | Completed | 2007-09-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00625573 | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) | Phase2 | Colorectal Cancer | Completed | 2007-09-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00547651 | AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer Afte… | Phase3 | Small Cell Lung Cancer | Completed | 2007-09-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00529022 | Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | Phase1 | Solid Tumors | Completed | 2007-08-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00521781 | Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or… | Phase2 | Prostatic Neoplasms | Terminated | 2007-08-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT01522547 | Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Poma… | Phase1 | Anemia, Sickle Cell | Completed | 2007-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00555100 | Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subject… | Phase1 | Multiple Myeloma | Completed | 2007-07-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00629473 | Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies | Phase1 | Advanced Cancer | Completed | 2007-07-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT00426764 | A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma | Phase2 | Peripheral T-cell Lymphoma | Completed | 2007-06-19 | 2018-05-17 | ClinicalTrials.gov |
| NCT00482261 | A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myelo… | Phase2 | Multiple Myeloma | Completed | 2007-06-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00480363 | QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Ob… | Phase3 | Multiple Myeloma | Completed | 2007-05-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00479674 | Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Me… | Phase2 | Breast Cancer | Completed | 2007-05-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT00596999 | A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Hum… | — | Hematologic Malignancies | Unknown | 2007-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00474188 | A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Ref… | Phase2 | Diffuse Large B-cell Lymphoma | Terminated | 2007-05-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00483301 | A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006)… | Phase2 | Malignant Melanoma | Completed | 2007-05-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00458159 | A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- … | Phase1 | Myelodysplastic Syndrome | Terminated | 2007-05-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00466895 | Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. | Phase1 | Acute Myeloid Leukemia | Completed | 2007-04-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT00463385 | A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia | Phase2 | Myelofibrosis With Myeloid Metaplasia | Completed | 2007-04-01 | 2013-12-31 | ClinicalTrials.gov |
| NCT00470548 | Abraxane and Alimta in Advanced Solid Tumors | Phase1 | Breast Cancer | Terminated | 2007-04-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00462423 | Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase I… | Phase2 | Metastatic Malignant Melanoma | Completed | 2007-04-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00477529 | ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer | Phase1 | Hormone Refractory Prostate Cancer | Completed | 2007-04-01 | 2011-06-02 | ClinicalTrials.gov |
| NCT01186939 | An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacit… | Phase3 | Myelodysplastic Syndromes | Completed | 2007-04-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00461045 | Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refrac… | Phase2 | Multiple Myeloma | Completed | 2007-03-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00478777 | A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide … | Phase3 | Relapsed or Refractory Multiple Myeloma | Completed | 2007-03-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00434239 | Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodyspl… | Early_Phase1 | Myelodysplasia | Unknown | 2007-02-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT00443261 | Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Ce… | Phase1 | Squamous Cell Carcinoma | Terminated | 2007-02-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00234000 | Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Synd… | Phase1 | Leukemia | Terminated | 2007-02-01 | — | ClinicalTrials.gov |
| NCT00407563 | Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer | Phase2 | Epithelial Ovarian Cancer | Completed | 2007-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00405756 | A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 … | Phase3 | Newly Diagnosed Multiple Myeloma | Completed | 2007-01-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT00478959 | Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodg… | Phase2 | Hodgkin Disease | Completed | 2006-12-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT00398086 | Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic … | Phase1 | Metastatic Pancreatic Cancer | Completed | 2006-11-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00431990 | A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With… | Phase1 | Multiple Myeloma | Unknown | 2006-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00375193 | Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progre… | Phase2 | Small Cell Lung Cancer | Completed | 2006-11-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00420849 | A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamet… | Phase3 | Multiple Myeloma | Completed | 2006-11-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00388960 | Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Ext… | Phase2 | Small Cell Lung Cancer | Completed | 2006-11-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00407407 | ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovar… | Phase1 | Fallopian Tube Neoplasms | Terminated | 2006-11-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00481273 | AVIDA The Vidaza® (Azacitidine) Patient Registry | — | Myelodysplastic Syndromes | Completed | 2006-10-31 | 2010-08-31 | ClinicalTrials.gov |
| NCT01028781 | Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associ… | Phase1 | Endometriosis | Terminated | 2006-10-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00392392 | Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ … | Phase2 | Breast Cancer | Completed | 2006-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00378105 | Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With… | Phase1 | Multiple Myeloma | Active_Not_Recruiting | 2006-09-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT00413478 | 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia | Phase2 | Chronic Lymphocytic Leukemia | Terminated | 2006-09-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT00379353 | The Effects of Thalidomide on Symptom Clusters | Phase2 | Advanced Cancers | Completed | 2006-09-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00379912 | Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-R… | Phase2 | Myelodysplastic Syndromes | Terminated | 2006-09-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00751296 | Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic … | Phase2 | Chronic Lymphocytic Leukaemia | Terminated | 2006-08-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT00394251 | Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Ab… | Phase2 | Breast Cancer | Completed | 2006-08-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00378209 | Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients Wi… | Phase2 | Multiple Myeloma | Completed | 2006-08-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT00387647 | Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) i… | Phase2 | Leukemia | Completed | 2006-08-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT00348595 | Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer | Phase1 | Prostate Cancer | Completed | 2006-07-20 | 2016-06-29 | ClinicalTrials.gov |
| NCT00352794 | Lenalidomide for Patients With Myelofibrosis (MF) | Phase2 | Myelofibrosis | Completed | 2006-07-07 | 2018-03-08 | ClinicalTrials.gov |
| NCT00379639 | A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patient… | Phase1 | Pancreatic Cancer | Completed | 2006-07-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00446303 | A Phase II Study of Maintenance With Azacitidine in MDS Patients | Phase2 | Leukemia, Myelocytic, Acute | Terminated | 2006-07-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00413036 | A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma | Phase2 | Lymphoma, Non-Hodgkin's | Completed | 2006-06-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00394082 | ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer | Phase2 | Metastatic Breast Cancer | Completed | 2006-06-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00322985 | A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma | Phase2 | T-cell Lymphoma | Completed | 2006-06-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT00349115 | TCD Followed by autoSCT for Newly Diagnosed MM Patients | Phase2 | Multiple Myeloma | Unknown | 2006-06-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00430365 | Maintenance Therapy Using Lenalidomide in Myeloma | Phase3 | Myeloma | Completed | 2006-06-01 | 2018-09-01 | ClinicalTrials.gov |
| NCT00331630 | Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage II… | Early_Phase1 | Breast Cancer | Completed | 2006-05-04 | 2010-08-05 | ClinicalTrials.gov |
| NCT00787436 | Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using … | Phase3 | Gastrointestinal Hemorrhage | Withdrawn | 2006-05-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00396864 | Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malign… | Phase1 | Cancer | Completed | 2006-05-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00454324 | Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer | Phase2 | Small Cell Lung Cancer | Terminated | 2006-04-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00953615 | Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) | Phase2 | Primary Sclerosing Cholangitis | Terminated | 2006-04-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00384839 | Vidaza to Restore Hormone Thx Prostate | Phase2 | Prostate Cancer | Completed | 2006-04-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00319969 | Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Can… | Phase2 | Small Cell Lung Cancer | Completed | 2006-04-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00308178 | Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer | Na | Breast Cancer | Completed | 2006-03-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00301405 | Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain | Phase2 | Chronic Prostatitis | Terminated | 2006-03-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00527657 | Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients | Phase1 | Brain Neoplasms | Completed | 2006-02-09 | 2012-02-02 | ClinicalTrials.gov |
| NCT00281528 | Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/B… | Phase2 | Breast Neoplasms | Terminated | 2006-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00287287 | REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and … | Phase2 | Thyroid Neoplasms | Completed | 2006-02-01 | 2010-07-06 | ClinicalTrials.gov |
| NCT00452569 | Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed … | Phase3 | Multiple Myeloma | Completed | 2006-02-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00294632 | Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (M… | Phase1 | Lymphoma | Completed | 2006-02-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT00337376 | A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination Wi… | Phase1 | Advanced Solid Cancers | Terminated | 2006-02-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00569010 | Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refracto… | Phase1 | Acute Myelogenous Leukemia | Completed | 2005-12-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00267059 | Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL) | Phase2 | Chronic Lymphocytic Leukemia | Completed | 2005-12-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00319865 | PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multipl… | Phase2 | Multiple Myeloma | Unknown | 2005-11-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00179725 | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated… | Phase1 | Ovarian Cancer | Terminated | 2005-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00249002 | Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients … | Phase2 | Hemodialysis Graft Dysfunction | Terminated | 2005-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00274456 | Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in Fi… | Phase2 | Metastatic Breast Cancer | Completed | 2005-11-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00466986 | Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer | Phase2 | Ovarian Cancer | Completed | 2005-11-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00350818 | Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (A… | Phase1 | Myelodysplastic Syndrome | Completed | 2005-10-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00126893 | Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Ri… | Phase1 | Myeloid Leukemia | Terminated | 2005-10-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00412581 | Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma | Phase1 | Melanoma | Completed | 2005-09-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00193206 | Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Infl… | Phase2 | Breast Cancer | Completed | 2005-09-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00179699 | Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Do… | Phase1 | Non-Small Cell Lung Cancer | Terminated | 2005-09-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00179647 | Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previousl… | Phase3 | Multiple Myeloma | Completed | 2005-09-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00179608 | Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients Wit… | Phase1 | Malignant Melanoma | Completed | 2005-09-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00177814 | Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit | — | Gram-negative Bacterial Infections | Completed | 2005-09-01 | 2017-06-01 | ClinicalTrials.gov |
| NCT00165477 | Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Mul… | Phase2 | Glioblastoma | Completed | 2005-09-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT01378091 | Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prost… | Phase1 | Prostate Cancer | Completed | 2005-08-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT00140140 | A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Pa… | Phase1 | Stage IV (Metastatic) Breast Cancer | Terminated | 2005-08-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00284752 | Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastat… | Phase2 | Prostate Cancer | Completed | 2005-08-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00179660 | Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Agg… | Phase2 | Non-Hodgkins Lymphoma | Completed | 2005-08-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00469703 | Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis | Phase2 | Chronic Pancreatitis | Terminated | 2005-08-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00284505 | Use of Thalidomide in Patients With Arachnoiditis | Phase2 | Arachnoiditis | Completed | 2005-07-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00124943 | Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Resteno… | Phase1 | Coronary Restenosis | Completed | 2005-07-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00256776 | MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After A… | Phase3 | Multiple Myeloma | Terminated | 2005-07-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT00766116 | Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Re… | Phase1 | Acute Myeloid Leukemia | Completed | 2005-07-01 | 2014-09-26 | ClinicalTrials.gov |
| NCT00981903 | Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous T… | Phase2 | Venous Thromboembolism | Terminated | 2005-07-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT00179621 | Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31]… | Phase3 | Myelodysplastic Syndromes | Completed | 2005-07-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00326170 | Phase II 5-Azacytidine Plus VPA Plus ATRA | Phase2 | Myelodysplastic Syndrome | Completed | 2005-07-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00569660 | Ph II Study of Azacitidine in Myelofibrosis | Phase2 | Myelofibrosis | Completed | 2005-06-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00179673 | Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indol… | Phase2 | Non-Hodgkins Lymphoma | Completed | 2005-06-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00496444 | Azacytidine and Valproic Acid in Patients With Advanced Cancers | Phase1 | Advanced Cancers | Completed | 2005-05-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00179712 | Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Prim… | Phase1 | Ovarian Cancer | Completed | 2005-04-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00110695 | Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) fo… | Phase2 | Breast Neoplasms | Completed | 2005-04-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00179751 | A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients … | Phase1 | Pancreatic Cancer | Terminated | 2005-04-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00179738 | A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficac… | Phase2 | Prostate Cancer | Terminated | 2005-04-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00179686 | A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent No… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2005-03-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00251472 | A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Trea… | Phase2 | Metastatic Breast Cancer | Completed | 2005-03-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00274443 | An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in C… | Phase2 | Non-Small Cell Lung Cancer (NSCLC) | Completed | 2005-03-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00107094 | Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Ther… | Phase1 | Breast Cancer | Completed | 2005-03-01 | — | ClinicalTrials.gov |
| NCT00109772 | Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of C… | Phase2 | Complex Regional Pain Syndrome, Type I | Terminated | 2005-02-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00140452 | Phase II Study Using Thalidomide for the Treatment of ALS | Phase2 | Amyotrophic Lateral Sclerosis | Completed | 2005-02-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00102687 | Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syn… | Phase2 | Myelodysplastic Syndromes | Completed | 2005-01-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00910858 | A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In … | Phase1 | Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) | Completed | 2005-01-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00120120 | Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of P… | Phase2 | Radiculopathy | Completed | 2005-01-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00106431 | A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatm… | Phase2 | Cutaneous T-cell Lymphoma | Completed | 2005-01-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00151203 | Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple My… | Phase2 | Multiple Myeloma | Completed | 2004-12-01 | 2020-09-29 | ClinicalTrials.gov |
| NCT00142168 | CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia | Phase2 | Waldenstrom's Macroglobulinemia | Terminated | 2004-09-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00087672 | A Phase II Study of CC-5013 in Myelofibrosis | Phase2 | Myelofibrosis | Completed | 2004-07-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00093145 | Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin an… | Phase2 | Breast Cancer | Completed | 2004-06-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00096044 | Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Re… | Phase2 | Leukemia | Completed | 2004-03-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00047281 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With … | Phase2 | Brain and Central Nervous System Tumors | Completed | 2004-03-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00629447 | Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients | Na | Primary Brain Tumor | Completed | 2004-02-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00091260 | CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemi… | Phase2 | Multiple Myeloma | Completed | 2004-01-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT00314665 | Use of Thalidomide in Chronic Uveitis | Phase4 | Uveitis | Terminated | 2004-01-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00074646 | Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractor… | Phase1 | Glioblastoma | Completed | 2003-12-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00073723 | Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanc… | Phase1 | Non-Small Cell Lung Cancer | Completed | 2003-12-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00071799 | A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing… | Phase3 | Myelodysplastic Syndromes | Completed | 2003-11-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00412542 | Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliom… | Phase2 | Glioblastoma Multiforme | Completed | 2003-10-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00162760 | Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide | Phase2 | Idiopathic Pulmonary Fibrosis (IPF) | Completed | 2003-10-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00072722 | Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory P… | Phase2 | Prostate Cancer | Completed | 2003-09-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00067743 | A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS) | Phase2 | Complex Regional Pain Syndrome (RSD) | Completed | 2003-08-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00093119 | Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma | Phase2 | Melanoma | Completed | 2003-07-01 | — | ClinicalTrials.gov |
| NCT00209014 | Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymph… | Phase2 | B-Cell Lymphoma | Terminated | 2003-07-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00065351 | Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refra… | Phase2 | Multiple Myeloma | Completed | 2003-07-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00064974 | Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplast… | Phase2 | Myelodysplastic Syndromes | Completed | 2003-06-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00065156 | Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With… | Phase2 | Myelodysplastic Syndromes | Completed | 2003-06-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00106418 | A Research Study for Patients With Prostate Cancer | Phase2 | Prostate Cancer | Completed | 2003-05-07 | 2006-09-01 | ClinicalTrials.gov |
| NCT00106613 | A Research Study for Patients With Metastatic Renal Cell Carcinoma | Phase2 | Carcinoma, Renal Cell | Completed | 2003-05-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00091624 | A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refract… | Phase1 | Multiple Myeloma | Completed | 2003-03-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00057564 | A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone… | Phase3 | Multiple Myeloma | Completed | 2003-02-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT00055562 | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjec… | Phase2 | Melanoma | Completed | 2003-01-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00424047 | A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously … | Phase3 | Multiple Myeloma | Completed | 2003-01-01 | 2013-11-12 | ClinicalTrials.gov |
| NCT00226980 | A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma | Phase2 | Kidney Neoplasms | Completed | 2002-10-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00098865 | Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neurobla… | Phase2 | Central Nervous System Tumor, Pediatric | Completed | 2002-09-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00040391 | A Trial of an Investigational Drug for the Prevention of Diarrhea Associated Wi… | Phase2 | Colorectal Neoplasms | Terminated | 2002-06-01 | — | ClinicalTrials.gov |
| NCT00047476 | D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemo… | Phase2 | Fatigue | Completed | 2002-06-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00051116 | A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Trea… | Phase2 | Multiple Myeloma | Completed | 2002-05-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00044018 | CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma | Phase2 | Multiple Myeloma | Completed | 2002-04-01 | 2007-02-15 | ClinicalTrials.gov |
| NCT00446433 | A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Mod… | Phase2 | Crohn's Disease | Completed | 2002-03-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00044382 | Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelody… | Phase2 | Myelodysplastic Syndrome | Completed | 2002-02-01 | 2007-01-30 | ClinicalTrials.gov |
| NCT00657488 | Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Mult… | Phase2 | Multiple Myeloma | Completed | 2001-12-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00045786 | Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatm… | Phase2 | Myelodysplastic Syndrome | Completed | 2001-10-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT00093223 | A Safety Study of ABI-007 for In-Stent Restenosis | Phase2 | Angina Pectoris | Completed | 2001-09-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00050843 | A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia… | Phase3 | Myelodysplastic Syndromes | Completed | 2001-08-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT00046527 | Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | Phase3 | Breast Neoplasms | Completed | 2001-06-01 | — | ClinicalTrials.gov |
| NCT00046514 | ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer | Phase2 | Breast Neoplasms | Completed | 2001-06-01 | — | ClinicalTrials.gov |
| NCT00193102 | Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast… | Phase2 | Breast Cancer | Terminated | 2001-04-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00038181 | Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select… | Phase2 | Prostate Cancer | Completed | 2000-10-05 | 2005-11-29 | ClinicalTrials.gov |
| NCT00038090 | Thalidomide-Dexamethasone for Multiple Myeloma | Phase2 | Multiple Myeloma | Completed | 2000-06-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00046423 | A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies | Phase1 | Neoplasms | Completed | 2000-04-01 | — | ClinicalTrials.gov |
| NCT00038233 | Thalidomide for Multiple Myeloma | Phase3 | Multiple Myeloma | Completed | 1999-05-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00083707 | Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macr… | Phase2 | Waldenstrom Macroglobulinemia | Completed | 1999-01-01 | 2003-02-01 | ClinicalTrials.gov |
| NCT00083876 | D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With… | Phase3 | Multiple Myeloma | Completed | 1998-09-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00083551 | UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomi… | Phase3 | Multiple Myeloma | Completed | 1998-08-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT00083694 | Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia | Phase2 | Leukemia | Completed | 1998-08-01 | 2005-05-01 | ClinicalTrials.gov |
Total clinical trials: 951
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Assessment of patient-reported outcomes (PROs) | Other | Preclinical | Esophageal Cancer | RECRUITING | NCT05177393 |
| Vehicle Control | Other | Phase PHASE2 | Crohn's Disease | COMPLETED | NCT01155362 |
| Human Placenta-Derived Cells PDA001 Intravenous Infusion | Other | Phase PHASE2 | Crohn's Disease | COMPLETED | NCT01155362 |
| Rituximab | Other | Phase PHASE1 | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma | ACTIVE_NOT_RECRUITING | NCT01829568 |
| Lenalidomide | Other | Phase PHASE1 | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma | ACTIVE_NOT_RECRUITING | NCT01829568 |
| Ibrutinib | Other | Phase PHASE1 | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma | ACTIVE_NOT_RECRUITING | NCT01829568 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| Rituximab | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| Rituximab | Other | Phase PHASE1 | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma | ACTIVE_NOT_RECRUITING | NCT01829568 |
| Lenalidomide | Other | Phase PHASE1 | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma | ACTIVE_NOT_RECRUITING | NCT01829568 |
| Ibrutinib | Other | Phase PHASE1 | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma | ACTIVE_NOT_RECRUITING | NCT01829568 |
| idelalisib | Other | Phase PHASE1 | Relapsed/Refractory Mantle Cell Lymphoma | COMPLETED | NCT01838434 |
| lenalidomide | Other | Phase PHASE1 | Relapsed/Refractory Mantle Cell Lymphoma | COMPLETED | NCT01838434 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Melphalan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Busulfan | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT01702831 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| Rituximab | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| etoposide | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| mitoxantrone | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| idarubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| daunorubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| cytarabine | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-221 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-120 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| Rituximab | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| etoposide | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| mitoxantrone | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| idarubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| daunorubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| cytarabine | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-221 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-120 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| Rituximab | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| etoposide | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| mitoxantrone | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| idarubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| daunorubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| cytarabine | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-221 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-120 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| Rituximab | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| etoposide | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| mitoxantrone | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| idarubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| daunorubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| cytarabine | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-221 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-120 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| Rituximab | Other | Phase PHASE2 | Leukemia | ACTIVE_NOT_RECRUITING | NCT01446133 |
| etoposide | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| mitoxantrone | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| idarubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| daunorubicin | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| cytarabine | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-221 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| AG-120 | Other | Phase PHASE1 | Newly Diagnosed Acute Myeloid Leukemia (AML) | ACTIVE_NOT_RECRUITING | NCT02632708 |
| Thalidomide | Other | Approved | HIV Infections | COMPLETED | NCT00002157 |
| Thalidomide | Other | Approved | HIV Infections | COMPLETED | NCT00002157 |
| CC-4047 | Other | Phase PHASE2 | Prostate Cancer | COMPLETED | NCT00072722 |
| CC-4047 | Other | Phase PHASE2 | Prostate Cancer | COMPLETED | NCT00072722 |
| CC-5013 | Other | Phase PHASE2 | Non-Small Cell Lung Cancer | COMPLETED | NCT00179686 |
| CC-5013 | Other | Phase PHASE2 | Non-Small Cell Lung Cancer | COMPLETED | NCT00179686 |
| Thalidomide | Other | Phase PHASE2 | Amyotrophic Lateral Sclerosis | COMPLETED | NCT00140452 |
| Thalidomide | Other | Phase PHASE2 | Amyotrophic Lateral Sclerosis | COMPLETED | NCT00140452 |
| Thalidomide | Other | Phase PHASE4 | Uveitis | TERMINATED | NCT00314665 |
| Thalidomide | Other | Phase PHASE4 | Uveitis | TERMINATED | NCT00314665 |
| CC 5013 | Other | Phase PHASE2 | Melanoma | COMPLETED | NCT00055562 |
| CC 5013 | Other | Phase PHASE2 | Melanoma | COMPLETED | NCT00055562 |
| CC 5013 | Other | Phase PHASE2 | Melanoma | COMPLETED | NCT00055562 |
| thalidomide | Other | Phase PHASE3 | Myelodysplastic Syndromes | COMPLETED | NCT00050843 |
| thalidomide | Other | Phase PHASE3 | Myelodysplastic Syndromes | COMPLETED | NCT00050843 |
| dexmethylphenidate(d-mph) | Other | Phase PHASE2 | Fatigue | COMPLETED | NCT00047476 |
| dexmethylphenidate(d-mph) | Other | Phase PHASE2 | Fatigue | COMPLETED | NCT00047476 |
| Thalidomide | Other | Phase PHASE2 | HIV Infections | COMPLETED | NCT00002127 |
| Thalidomide | Other | Phase PHASE2 | HIV Infections | COMPLETED | NCT00002127 |
| gemcitabine | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT00179751 |
| CC-5013 | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT00179751 |
| gemcitabine | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT00179751 |
| CC-5013 | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT00179751 |
| gemcitabine | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT00179751 |
| CC-5013 | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT00179751 |
| pemetrexed | Other | Phase PHASE1 | Non-Small Cell Lung Cancer | TERMINATED | NCT00179699 |
| CC-5013 | Other | Phase PHASE1 | Non-Small Cell Lung Cancer | TERMINATED | NCT00179699 |
| pemetrexed | Other | Phase PHASE1 | Non-Small Cell Lung Cancer | TERMINATED | NCT00179699 |
| CC-5013 | Other | Phase PHASE1 | Non-Small Cell Lung Cancer | TERMINATED | NCT00179699 |
| pemetrexed | Other | Phase PHASE1 | Non-Small Cell Lung Cancer | TERMINATED | NCT00179699 |
| CC-5013 | Other | Phase PHASE1 | Non-Small Cell Lung Cancer | TERMINATED | NCT00179699 |
| CC5013 | Other | Phase PHASE2 | Prostate Cancer | TERMINATED | NCT00179738 |
| liposomal doxorubicin | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT00179725 |
| CC-5013 | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT00179725 |
| liposomal doxorubicin | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT00179725 |
| CC-5013 | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT00179725 |
| Dexamethasone | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| Adriamycin | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| Thalidomide | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| Velcade | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| Dexamethasone | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| Adriamycin | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| Thalidomide | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| Velcade | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00319865 |
| ABI-007 | Other | Phase PHASE3 | Breast Neoplasms | COMPLETED | NCT00046527 |
| ABI-007 | Other | Phase PHASE3 | Breast Neoplasms | COMPLETED | NCT00046527 |
| CC-5013 | Other | Phase PHASE2 | Non-Small Cell Lung Cancer | COMPLETED | NCT00179686 |
| CC-8490 | Other | Phase PHASE1 | Glioblastoma | COMPLETED | NCT00074646 |
| CC-8490 | Other | Phase PHASE1 | Glioblastoma | COMPLETED | NCT00074646 |
| CC-401 | Other | Phase PHASE1 | Myeloid Leukemia | TERMINATED | NCT00126893 |
| Abraxane | Other | Phase PHASE1 | Breast Cancer | COMPLETED | NCT00107094 |
| Abraxane | Other | Phase PHASE1 | Breast Cancer | COMPLETED | NCT00107094 |
| Lenalidomide | Other | Phase PHASE2 | Complex Regional Pain Syndrome (RSD) | COMPLETED | NCT00067743 |
| Lenalidomide | Other | Phase PHASE2 | Complex Regional Pain Syndrome (RSD) | COMPLETED | NCT00067743 |
| Lenalidomide | Other | Phase PHASE2 | Complex Regional Pain Syndrome (RSD) | COMPLETED | NCT00067743 |
| Thalidomide | Other | Phase PHASE2 | Chronic Pancreatitis | TERMINATED | NCT00469703 |
| Thalidomide | Other | Phase PHASE2 | Idiopathic Pulmonary Fibrosis (IPF) | COMPLETED | NCT00162760 |
| Thalidomide | Other | Phase PHASE2 | Idiopathic Pulmonary Fibrosis (IPF) | COMPLETED | NCT00162760 |
| Apremilast | Other | Phase PHASE2 | Atopic Dermatitis | COMPLETED | NCT00931242 |
| Thalidomide | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00349115 |
| Thalidomide | Other | Phase PHASE2 | Multiple Myeloma | UNKNOWN | NCT00349115 |
| Amrubicin | Other | Phase PHASE2 | Metastatic Breast Cancer | WITHDRAWN | NCT00380835 |
| thalidomide | Other | Phase PHASE2 | Arachnoiditis | COMPLETED | NCT00284505 |
| thalidomide | Other | Phase PHASE2 | Arachnoiditis | COMPLETED | NCT00284505 |
| Capecitabine | Other | Phase PHASE2 | Kidney Neoplasms | COMPLETED | NCT00226980 |
| Thalidomide | Other | Phase PHASE2 | Kidney Neoplasms | COMPLETED | NCT00226980 |
| Capecitabine | Other | Phase PHASE2 | Kidney Neoplasms | COMPLETED | NCT00226980 |
| Thalidomide | Other | Phase PHASE2 | Kidney Neoplasms | COMPLETED | NCT00226980 |
| Thalidomide | Other | Phase PHASE2 | B-Cell Lymphoma | TERMINATED | NCT00209014 |
| Thalidomide | Other | Phase PHASE2 | B-Cell Lymphoma | TERMINATED | NCT00209014 |
| dexamethasone | Other | Phase PHASE2 | Diffuse Large B-cell Lymphoma | TERMINATED | NCT00474188 |
| CC-5013 (lenalidomide) | Other | Phase PHASE2 | Diffuse Large B-cell Lymphoma | TERMINATED | NCT00474188 |
| dexamethasone | Other | Phase PHASE2 | Diffuse Large B-cell Lymphoma | TERMINATED | NCT00474188 |
| CC-5013 (lenalidomide) | Other | Phase PHASE2 | Diffuse Large B-cell Lymphoma | TERMINATED | NCT00474188 |
| dexamethasone | Other | Phase PHASE2 | Diffuse Large B-cell Lymphoma | TERMINATED | NCT00474188 |
| CC-5013 (lenalidomide) | Other | Phase PHASE2 | Diffuse Large B-cell Lymphoma | TERMINATED | NCT00474188 |
| Abraxane | Other | Phase PHASE2 | Colorectal Cancer | COMPLETED | NCT00625573 |
| Abraxane | Other | Phase PHASE2 | Colorectal Cancer | COMPLETED | NCT00625573 |
| Lenalidomide (CC-5013) | Other | Phase PHASE2 | Radiculopathy | COMPLETED | NCT00120120 |
| Lenalidomide (CC-5013) | Other | Phase PHASE2 | Radiculopathy | COMPLETED | NCT00120120 |
| CC-5013 | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00051116 |
| Topotecan | Other | Phase PHASE2 | Small Cell Lung Cancer | COMPLETED | NCT00319969 |
| Amrubicin | Other | Phase PHASE2 | Small Cell Lung Cancer | COMPLETED | NCT00319969 |
| Topotecan | Other | Phase PHASE2 | Small Cell Lung Cancer | COMPLETED | NCT00319969 |
| Amrubicin | Other | Phase PHASE2 | Small Cell Lung Cancer | COMPLETED | NCT00319969 |
| Apremilast (CC-10004) | Other | Phase PHASE2 | Lichen Planus | UNKNOWN | NCT01041625 |
| Apremilast (CC-10004) | Other | Phase PHASE2 | Lichen Planus | UNKNOWN | NCT01041625 |
| Radiation | Other | Phase PHASE2 | Glioblastoma | COMPLETED | NCT00165477 |
| lenalidomide | Other | Phase PHASE2 | Glioblastoma | COMPLETED | NCT00165477 |
| Radiation | Other | Phase PHASE2 | Glioblastoma | COMPLETED | NCT00165477 |
| lenalidomide | Other | Phase PHASE2 | Glioblastoma | COMPLETED | NCT00165477 |
| Radiation | Other | Phase PHASE2 | Glioblastoma | COMPLETED | NCT00165477 |
| lenalidomide | Other | Phase PHASE2 | Glioblastoma | COMPLETED | NCT00165477 |
| dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00179647 |
| lenalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00179647 |
| dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00179647 |
| lenalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00179647 |
| dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00179647 |
| lenalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00179647 |
| Nanoparticle albumin bound paclitaxel followed by FEC | Other | Phase PHASE2 | Breast Neoplasms | COMPLETED | NCT00110695 |
| Nanoparticle albumin bound paclitaxel followed by FEC | Other | Phase PHASE2 | Breast Neoplasms | COMPLETED | NCT00110695 |
| Nanoparticle albumin bound paclitaxel followed by FEC | Other | Phase PHASE2 | Breast Neoplasms | COMPLETED | NCT00110695 |
| Lenalidomide | Other | Phase PHASE2 | Cutaneous T Cell Lymphoma | UNKNOWN | NCT01132989 |
| Lenalidomide | Other | Phase PHASE2 | Cutaneous T Cell Lymphoma | UNKNOWN | NCT01132989 |
| Thalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00083876 |
| Thalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00083876 |
| Thalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00083876 |
| Thalidomide | Other | Phase PHASE2 | Leukemia | COMPLETED | NCT00083694 |
| Thalidomide | Other | Phase PHASE2 | Waldenstrom Macroglobulinemia | COMPLETED | NCT00083707 |
| Thalidomide | Other | Phase PHASE2 | Waldenstrom Macroglobulinemia | COMPLETED | NCT00083707 |
| Cetuximab | Other | Phase PHASE1 | Solid Tumors | UNKNOWN | NCT01166035 |
| Lenalidomide | Other | Phase PHASE1 | Solid Tumors | UNKNOWN | NCT01166035 |
| Cetuximab | Other | Phase PHASE1 | Solid Tumors | UNKNOWN | NCT01166035 |
| Lenalidomide | Other | Phase PHASE1 | Solid Tumors | UNKNOWN | NCT01166035 |
| Lenalidomide and Rituximab | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | UNKNOWN | NCT00628238 |
| Lenalidomide and Rituximab | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | UNKNOWN | NCT00628238 |
| Lenalidomide, Bendamustine, Prednisone | Other | Phase PHASE1 | Multiple Myeloma | UNKNOWN | NCT01002703 |
| dexamethasone | Other | Phase PHASE1 | Multiple Myeloma | UNKNOWN | NCT00431990 |
| bortezomib | Other | Phase PHASE1 | Multiple Myeloma | UNKNOWN | NCT00431990 |
| depsipeptide | Other | Phase PHASE1 | Multiple Myeloma | UNKNOWN | NCT00431990 |
| Lenalidomide (CC-5013) | Other | Phase PHASE1 | Advanced Solid Tumors | UNKNOWN | NCT01155505 |
| Lenalidomide (CC-5013) | Other | Phase PHASE1 | Advanced Solid Tumors | UNKNOWN | NCT01155505 |
| Abraxane | Other | Phase PHASE2 | Ovarian Cancer | COMPLETED | NCT00466986 |
| Abraxane | Other | Phase PHASE2 | Ovarian Cancer | COMPLETED | NCT00466986 |
| dexamethasone | Other | Phase PHASE3 | Relapsed or Refractory Multiple Myeloma | COMPLETED | NCT00478777 |
| Lenalidomide | Other | Phase PHASE3 | Relapsed or Refractory Multiple Myeloma | COMPLETED | NCT00478777 |
| dexamethasone | Other | Phase PHASE3 | Relapsed or Refractory Multiple Myeloma | COMPLETED | NCT00478777 |
| Lenalidomide | Other | Phase PHASE3 | Relapsed or Refractory Multiple Myeloma | COMPLETED | NCT00478777 |
| dexamethasone | Other | Phase PHASE3 | Relapsed or Refractory Multiple Myeloma | COMPLETED | NCT00478777 |
| Lenalidomide | Other | Phase PHASE3 | Relapsed or Refractory Multiple Myeloma | COMPLETED | NCT00478777 |
| Lenalidomide | Other | Phase PHASE2 | Chronic Lymphocytic Leukaemia | TERMINATED | NCT01127542 |
| Thalidomide | Other | Phase PHASE1 | Endometriosis | TERMINATED | NCT01028781 |
| Thalidomide | Other | Phase PHASE1 | Endometriosis | TERMINATED | NCT01028781 |
| Azacitidine | Other | Phase PHASE2 | Leukemia, Myelocytic, Acute | TERMINATED | NCT00446303 |
| Azacitidine | Other | Phase PHASE2 | Leukemia, Myelocytic, Acute | TERMINATED | NCT00446303 |
| Thalidomide | Other | Phase PHASE2 | Primary Sclerosing Cholangitis | TERMINATED | NCT00953615 |
| Thalidomide | Other | Phase PHASE2 | Primary Sclerosing Cholangitis | TERMINATED | NCT00953615 |
| Lenalidomide, dexamethasone | Other | Phase PHASE2 | Primary Plasma Cell Leukemia | COMPLETED | NCT01553357 |
| Lenalidomide, dexamethasone | Other | Phase PHASE2 | Primary Plasma Cell Leukemia | COMPLETED | NCT01553357 |
| All-Trans Retinoic Acid (ATRA) | Other | Phase PHASE2 | Myelodysplastic Syndrome | COMPLETED | NCT00326170 |
| Valproic Acid | Other | Phase PHASE2 | Myelodysplastic Syndrome | COMPLETED | NCT00326170 |
| 5-Azacytidine (5-aza) | Other | Phase PHASE2 | Myelodysplastic Syndrome | COMPLETED | NCT00326170 |
| All-Trans Retinoic Acid (ATRA) | Other | Phase PHASE2 | Myelodysplastic Syndrome | COMPLETED | NCT00326170 |
| Valproic Acid | Other | Phase PHASE2 | Myelodysplastic Syndrome | COMPLETED | NCT00326170 |
| 5-Azacytidine (5-aza) | Other | Phase PHASE2 | Myelodysplastic Syndrome | COMPLETED | NCT00326170 |
| Ara-C | Other | Phase PHASE1 | Acute Myelogenous Leukemia | COMPLETED | NCT00569010 |
| Azacitidine | Other | Phase PHASE1 | Acute Myelogenous Leukemia | COMPLETED | NCT00569010 |
| dexamethasone | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| lenalidomide | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| cyclophosphamide | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| dexamethasone | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| lenalidomide | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| cyclophosphamide | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| dexamethasone | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| lenalidomide | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| cyclophosphamide | Other | Phase PHASE2 | Amyloidosis | COMPLETED | NCT00607581 |
| Quantitative Sensory Tests (QST) | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| MRI Scan | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| CPT-11 | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| Thalidomide | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| Quantitative Sensory Tests (QST) | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| MRI Scan | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| CPT-11 | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| Thalidomide | Other | Phase PHASE2 | Glioblastoma Multiforme | COMPLETED | NCT00412542 |
| Lenalidomide | Other | Phase PHASE1 | Myelodysplasia | COMPLETED | NCT00580242 |
| Bortezomib | Other | Phase PHASE1 | Myelodysplasia | COMPLETED | NCT00580242 |
| Lenalidomide | Other | Phase PHASE1 | Myelodysplasia | COMPLETED | NCT00580242 |
| Bortezomib | Other | Phase PHASE1 | Myelodysplasia | COMPLETED | NCT00580242 |
| Nanoparticle Paclitaxel | Other | Phase PHASE2 | Vascular Disease, Peripheral | TERMINATED | NCT00518284 |
| Nanoparticle Paclitaxel | Other | Phase PHASE1 | Coronary Restenosis | COMPLETED | NCT00124943 |
| Nanoparticle Paclitaxel | Other | Phase PHASE1 | Coronary Restenosis | COMPLETED | NCT00124943 |
| Nanoparticle Paclitaxel | Other | Phase PHASE1 | Coronary Restenosis | COMPLETED | NCT00124943 |
| UCB and HPDSC | Other | Preclinical | Hematologic Malignancies | UNKNOWN | NCT00596999 |
| UCB and HPDSC | Other | Preclinical | Hematologic Malignancies | UNKNOWN | NCT00596999 |
| ABI-007(Abraxane) | Other | Phase PHASE2 | Malignant Melanoma | COMPLETED | NCT00483301 |
| Sorafenib (BAY 43-9006) | Other | Phase PHASE2 | Malignant Melanoma | COMPLETED | NCT00483301 |
| ABI-007(Abraxane) | Other | Phase PHASE2 | Malignant Melanoma | COMPLETED | NCT00483301 |
| Sorafenib (BAY 43-9006) | Other | Phase PHASE2 | Malignant Melanoma | COMPLETED | NCT00483301 |
| ABI-007(Abraxane) | Other | Phase PHASE2 | Malignant Melanoma | COMPLETED | NCT00483301 |
| Sorafenib (BAY 43-9006) | Other | Phase PHASE2 | Malignant Melanoma | COMPLETED | NCT00483301 |
| Paclitaxel Albumin Nanoparticle for Injectable Suspension | Other | Phase PHASE2 | Metastatic Breast Cancer | COMPLETED | NCT00251472 |
| Paclitaxel Albumin Nanoparticle for Injectable Suspension | Other | Phase PHASE2 | Metastatic Breast Cancer | COMPLETED | NCT00251472 |
| Dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00420849 |
| Lenalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00420849 |
| Dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00420849 |
| Lenalidomide | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00420849 |
| RAD | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00925821 |
| allogeneic stem cell transplant versus second autologous transplantation | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00925821 |
| RAD | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00925821 |
| allogeneic stem cell transplant versus second autologous transplantation | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00925821 |
| Azacitidine | Other | Phase PHASE1 | Myelodysplastic Syndrome | COMPLETED | NCT00350818 |
| Valproic Acid | Other | Phase PHASE1 | Advanced Cancers | COMPLETED | NCT00496444 |
| Azacitidine | Other | Phase PHASE1 | Advanced Cancers | COMPLETED | NCT00496444 |
| Valproic Acid | Other | Phase PHASE1 | Advanced Cancers | COMPLETED | NCT00496444 |
| Azacitidine | Other | Phase PHASE1 | Advanced Cancers | COMPLETED | NCT00496444 |
| Darbepoetin alfa | Other | Phase PHASE2 | Leukemia | TERMINATED | NCT01222195 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | TERMINATED | NCT01222195 |
| Darbepoetin alfa | Other | Phase PHASE2 | Leukemia | TERMINATED | NCT01222195 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | TERMINATED | NCT01222195 |
| Darbepoetin alfa | Other | Phase PHASE2 | Leukemia | TERMINATED | NCT01222195 |
| Lenalidomide | Other | Phase PHASE2 | Leukemia | TERMINATED | NCT01222195 |
| Azacitidine | Other | Phase PHASE2 | Myelofibrosis | COMPLETED | NCT00569660 |
| Azacitidine | Other | Phase PHASE2 | Myelofibrosis | COMPLETED | NCT00569660 |
| Lenalidomide | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | COMPLETED | NCT00267059 |
| Lenalidomide | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | COMPLETED | NCT00267059 |
| Lenalidomide | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | COMPLETED | NCT00267059 |
| CC-5013 | Other | Phase PHASE2 | Myelofibrosis | COMPLETED | NCT00087672 |
| CC-5013 | Other | Phase PHASE2 | Myelofibrosis | COMPLETED | NCT00087672 |
| Abraxane | Other | Phase PHASE2 | Prostate Cancer | COMPLETED | NCT00284752 |
| nab-paclitaxel, gemcitabine, capecitabine | Other | Phase PHASE1 | Pancreatic Neoplasms | COMPLETED | NCT01161186 |
| lenalidomide | Other | Phase PHASE2 | Myelodysplastic Syndromes | TERMINATED | NCT00720850 |
| lenalidomide | Other | Phase PHASE2 | Myelodysplastic Syndromes | TERMINATED | NCT00720850 |
| Placebo | Other | Phase PHASE2 | Erosive Osteoarthritis of the Hand | COMPLETED | NCT01200472 |
| Apremilast | Other | Phase PHASE2 | Erosive Osteoarthritis of the Hand | COMPLETED | NCT01200472 |
| standard chemotherapy (7+3 scheme): Daunorubicin, Cytarabine | Drug | Phase PHASE2 | Acute Myeloid Leukemia | COMPLETED | NCT00915252 |
| azacitidine | Other | Phase PHASE2 | Acute Myeloid Leukemia | COMPLETED | NCT00915252 |
| standard chemotherapy (7+3 scheme): Daunorubicin, Cytarabine | Drug | Phase PHASE2 | Acute Myeloid Leukemia | COMPLETED | NCT00915252 |
| azacitidine | Other | Phase PHASE2 | Acute Myeloid Leukemia | COMPLETED | NCT00915252 |
| Bevacizumab, nab-paclitaxel, carboplatin, doxorubicin hydrochloride, cyclophosphamide, PEG-Filgrastim | Other | Phase PHASE2 | Breast Cancer | UNKNOWN | NCT00777673 |
| Bevacizumab, nab-paclitaxel, carboplatin, doxorubicin hydrochloride, cyclophosphamide, PEG-Filgrastim | Other | Phase PHASE2 | Breast Cancer | UNKNOWN | NCT00777673 |
| Innohep | Other | Approved | Primary Brain Tumor | COMPLETED | NCT00629447 |
| Innohep | Other | Approved | Primary Brain Tumor | COMPLETED | NCT00629447 |
| Lenalidomide + Ancestim | Other | Phase EARLY_PHASE1 | Myelodysplasia | UNKNOWN | NCT00434239 |
| Lenalidomide + Ancestim | Other | Phase EARLY_PHASE1 | Myelodysplasia | UNKNOWN | NCT00434239 |
| Lenalidomide | Other | Phase PHASE2 | Advanced Cancer | TERMINATED | NCT00684242 |
| Lenalidomide | Other | Phase PHASE2 | Advanced Cancer | TERMINATED | NCT00684242 |
| Placebo | Other | Phase PHASE2 | Advanced Cancers | COMPLETED | NCT00379353 |
| Thalidomide | Other | Phase PHASE2 | Advanced Cancers | COMPLETED | NCT00379353 |
| Placebo | Other | Phase PHASE2 | Advanced Cancers | COMPLETED | NCT00379353 |
| Thalidomide | Other | Phase PHASE2 | Advanced Cancers | COMPLETED | NCT00379353 |
| Placebo | Other | Phase PHASE2 | Advanced Cancers | COMPLETED | NCT00379353 |
| Thalidomide | Other | Phase PHASE2 | Advanced Cancers | COMPLETED | NCT00379353 |
| Abraxane | Other | Approved | Breast Cancer | COMPLETED | NCT00308178 |
| Abraxane | Other | Approved | Breast Cancer | COMPLETED | NCT00308178 |
| Abraxane | Other | Approved | Breast Cancer | COMPLETED | NCT00308178 |
| Carboplatin | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Valproic Acid | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Azacitidine | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Carboplatin | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Valproic Acid | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Azacitidine | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Carboplatin | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Valproic Acid | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| Azacitidine | Other | Phase PHASE1 | Solid Tumors | COMPLETED | NCT00529022 |
| CC-5013 | Other | Phase PHASE2 | Myelodysplastic Syndromes | COMPLETED | NCT00064974 |
| CC-5013 | Other | Phase PHASE2 | Myelodysplastic Syndromes | COMPLETED | NCT00064974 |
| CC-100004 | Other | Phase PHASE2 | Sarcoidosis | COMPLETED | NCT00794274 |
| CC-100004 | Other | Phase PHASE2 | Sarcoidosis | COMPLETED | NCT00794274 |
| lenalidomide | Other | Phase PHASE2 | Colorectal Cancer | TERMINATED | NCT01032291 |
| cetuximab | Other | Phase PHASE2 | Colorectal Cancer | TERMINATED | NCT01032291 |
| lenalidomide | Other | Phase PHASE2 | Colorectal Cancer | TERMINATED | NCT01032291 |
| cetuximab | Other | Phase PHASE2 | Colorectal Cancer | TERMINATED | NCT01032291 |
| Romidepsin | Other | Phase EARLY_PHASE1 | Histologically Proven Extranodal NKTcell Lymphoma | COMPLETED | NCT01913119 |
| Romidepsin | Other | Phase EARLY_PHASE1 | Histologically Proven Extranodal NKTcell Lymphoma | COMPLETED | NCT01913119 |
| Thalidomide | Other | Phase PHASE3 | Gastrointestinal Hemorrhage | WITHDRAWN | NCT00787436 |
| Thalidomide | Other | Phase PHASE3 | Gastrointestinal Hemorrhage | WITHDRAWN | NCT00787436 |
| Maintenance with lower doses of lenalidomide and dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00480363 |
| Maintenance with lower doses of lenalidomide and dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00480363 |
| Maintenance with lower doses of lenalidomide and dexamethasone | Other | Phase PHASE3 | Multiple Myeloma | COMPLETED | NCT00480363 |
| Thalidomide | Other | Phase PHASE2 | Chronic Prostatitis | TERMINATED | NCT00301405 |
| Revlimid | Other | Phase PHASE2 | Acute Myelogenous Leukemia | COMPLETED | NCT00360672 |
| Revlimid | Other | Phase PHASE2 | Acute Myelogenous Leukemia | COMPLETED | NCT00360672 |
| Revlimid | Other | Phase PHASE2 | Acute Myelogenous Leukemia | COMPLETED | NCT00360672 |
| Placebo | Other | Phase PHASE2 | Complex Regional Pain Syndrome, Type I | TERMINATED | NCT00109772 |
| lenalidomide | Other | Phase PHASE2 | Complex Regional Pain Syndrome, Type I | TERMINATED | NCT00109772 |
| Placebo | Other | Phase PHASE2 | Complex Regional Pain Syndrome, Type I | TERMINATED | NCT00109772 |
| lenalidomide | Other | Phase PHASE2 | Complex Regional Pain Syndrome, Type I | TERMINATED | NCT00109772 |
| Rituximab | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | COMPLETED | NCT00738829 |
| Fludarabine | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | COMPLETED | NCT00738829 |
| Lenalidomide | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | COMPLETED | NCT00738829 |
| Rituximab | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | COMPLETED | NCT00738829 |
| Fludarabine | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | COMPLETED | NCT00738829 |
| Lenalidomide | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | COMPLETED | NCT00738829 |
| Lenalidomide, Decitabine | Other | Phase PHASE1 | Myelodysplastic Syndromes | COMPLETED | NCT00828802 |
| lenalidomide | Other | Phase PHASE2 | Myelodysplastic Syndromes | TERMINATED | NCT00720850 |
| Lenalidomida and Rituximab | Other | Phase PHASE1 | Chronic Lymphocytic Leukemia | COMPLETED | NCT01185262 |
| Recombinant human erythropoietin | Other | Phase PHASE1 | Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) | COMPLETED | NCT00910858 |
| Lenalidomide | Other | Phase PHASE1 | Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) | COMPLETED | NCT00910858 |
| Recombinant human erythropoietin | Other | Phase PHASE1 | Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) | COMPLETED | NCT00910858 |
| Lenalidomide | Other | Phase PHASE1 | Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) | COMPLETED | NCT00910858 |
| Placebo | Other | Phase PHASE2 | Erosive Osteoarthritis of the Hand | COMPLETED | NCT01200472 |
| Apremilast | Other | Phase PHASE2 | Erosive Osteoarthritis of the Hand | COMPLETED | NCT01200472 |
| Lenalidomide | Other | Phase PHASE2 | Graft-versus-Host Disease | TERMINATED | NCT00675441 |
| Lenalidomide | Other | Phase PHASE2 | Graft-versus-Host Disease | TERMINATED | NCT00675441 |
| Lenalidomide | Other | Phase PHASE1 | Myelodysplastic Syndromes | TERMINATED | NCT00923234 |
| Azacitidine | Other | Phase PHASE1 | Myelodysplastic Syndromes | TERMINATED | NCT00923234 |
| Lenalidomide | Other | Phase PHASE1 | Myelodysplastic Syndromes | TERMINATED | NCT00923234 |
| Azacitidine | Other | Phase PHASE1 | Myelodysplastic Syndromes | TERMINATED | NCT00923234 |
| Lenalidomide | Other | Phase PHASE1 | Myelodysplastic Syndromes | TERMINATED | NCT00923234 |
| Azacitidine | Other | Phase PHASE1 | Myelodysplastic Syndromes | TERMINATED | NCT00923234 |
| Revlimid, Doxil, Avastin | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT01202890 |
| Lenalidomide, Liposomal Doxorubicin, Bevacizumab | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT01202890 |
| Revlimid, Doxil, Avastin | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT01202890 |
| Lenalidomide, Liposomal Doxorubicin, Bevacizumab | Other | Phase PHASE1 | Ovarian Cancer | TERMINATED | NCT01202890 |
| Abraxane | Other | Phase PHASE2 | Metastatic Malignant Melanoma | COMPLETED | NCT00462423 |
| Avastin | Other | Phase PHASE2 | Metastatic Malignant Melanoma | COMPLETED | NCT00462423 |
| Abraxane | Other | Phase PHASE2 | Metastatic Malignant Melanoma | COMPLETED | NCT00462423 |
| Avastin | Other | Phase PHASE2 | Metastatic Malignant Melanoma | COMPLETED | NCT00462423 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02034773 |
| CC-220 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02034773 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02034773 |
| CC-220 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02034773 |
| Abraxane | Other | Phase PHASE1 | Advanced Solid Cancers | TERMINATED | NCT00337376 |
| Rapamune | Other | Phase PHASE1 | Advanced Solid Cancers | TERMINATED | NCT00337376 |
| Abraxane | Other | Phase PHASE1 | Advanced Solid Cancers | TERMINATED | NCT00337376 |
| Rapamune | Other | Phase PHASE1 | Advanced Solid Cancers | TERMINATED | NCT00337376 |
| Abraxane | Other | Phase PHASE1 | Advanced Solid Cancers | TERMINATED | NCT00337376 |
| Rapamune | Other | Phase PHASE1 | Advanced Solid Cancers | TERMINATED | NCT00337376 |
| Dexamethasone | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00617591 |
| Pegylated Liposomal Doxorubicin (PLD) | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00617591 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00617591 |
| Dexamethasone | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00617591 |
| Pegylated Liposomal Doxorubicin (PLD) | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00617591 |
| Lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00617591 |
| Abraxane | Other | Phase PHASE2 | Metastatic Melanoma | WITHDRAWN | NCT01933061 |
| Abraxane | Other | Phase PHASE2 | Metastatic Melanoma | WITHDRAWN | NCT01933061 |
| Abraxane | Other | Phase PHASE2 | Metastatic Melanoma | WITHDRAWN | NCT01933061 |
| Epoetin beta | Other | Phase PHASE2 | Myelodysplastic Syndromes | COMPLETED | NCT01015352 |
| Azacitidine | Other | Phase PHASE2 | Myelodysplastic Syndromes | COMPLETED | NCT01015352 |
| Revlimid | Other | Phase PHASE2 | Prostate Cancer | COMPLETED | NCT00654186 |
| lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00847639 |
| lenalidomide | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00847639 |
| Vidaza | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT01167816 |
| Vidaza | Other | Phase PHASE1 | Pancreatic Cancer | TERMINATED | NCT01167816 |
| Apremilast | Other | Phase PHASE1 | Uveitis | TERMINATED | NCT00889421 |
| Apremilast | Other | Phase PHASE1 | Uveitis | TERMINATED | NCT00889421 |
| Lenalidomide, Rituximab, and Cyclophosphamide | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | TERMINATED | NCT01005979 |
| Lenalidomide, Rituximab, and Cyclophosphamide | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | TERMINATED | NCT01005979 |
| Lenalidomide, Rituximab, and Cyclophosphamide | Other | Phase PHASE1 | Leukemia, Lymphocytic, Chronic, B-Cell | TERMINATED | NCT01005979 |
| Sequential Maintenance Therapy | Drug | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00691704 |
| Lenalidomide Induction | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00691704 |
| Sequential Maintenance Therapy | Drug | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00691704 |
| Lenalidomide Induction | Other | Phase PHASE2 | Multiple Myeloma | COMPLETED | NCT00691704 |
| Azacitidine | Other | Phase PHASE2 | Leukemia | COMPLETED | NCT00387647 |
| Azacitidine | Other | Phase PHASE2 | Leukemia | COMPLETED | NCT00387647 |
| Allogeneic Hematopoietic Cell Transplantation (HCT) | Other | Approved | Leukemia | COMPLETED | NCT00660400 |
| 5-azacitidine | Other | Approved | Leukemia | COMPLETED | NCT00660400 |
| CC-10004 | Other | Phase PHASE2 | Prostatitis | COMPLETED | NCT00701311 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02110420 |
| CC-90001 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02110420 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02110420 |
| CC-90001 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02110420 |
| Placebo | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02110420 |
| CC-90001 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT02110420 |
| Maintenance lenalidomide | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | TERMINATED | NCT01465230 |
| Revlimid | Other | Phase PHASE2 | Acute Myeloid Leukemia | COMPLETED | NCT00957385 |
| Lenalidomide | Other | Phase PHASE2 | Non-Hodgkins Lymphoma | COMPLETED | NCT00179660 |
| Lenalidomide | Other | Phase PHASE2 | Non-Hodgkins Lymphoma | COMPLETED | NCT00179660 |
| Lenalidomide | Other | Phase PHASE2 | Non-Hodgkins Lymphoma | COMPLETED | NCT00179660 |
| Prednisone | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01378091 |
| Docetaxel | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01378091 |
| Lenalidomide | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01378091 |
| Prednisone | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01378091 |
| Docetaxel | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01378091 |
| Lenalidomide | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01378091 |
| Itraconazole | Other | Phase PHASE1 | Pharmacokinetics | COMPLETED | NCT02820935 |
| Rifampin | Other | Phase PHASE1 | Pharmacokinetics | COMPLETED | NCT02820935 |
| CC-220 | Other | Phase PHASE1 | Pharmacokinetics | COMPLETED | NCT02820935 |
| Paclitaxel | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| Lenalidomide | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| Paclitaxel | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| Lenalidomide | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| Paclitaxel | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| Lenalidomide | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| Paclitaxel | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| Lenalidomide | Other | Phase PHASE1 | Prostate Cancer | TERMINATED | NCT00933426 |
| ABI-007 | Other | Phase PHASE1 | Neoplasms | COMPLETED | NCT00046423 |
| ABI-007 | Other | Phase PHASE1 | Neoplasms | COMPLETED | NCT00046423 |
| Lenalidomide | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | TERMINATED | NCT01600053 |
| Lenalidomide | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | TERMINATED | NCT01600053 |
| lenalidomide | Other | Phase PHASE1 | Acute Myeloid Leukemia | COMPLETED | NCT00466895 |
| Lenalidomide | Other | Phase PHASE1 | Multiple Myeloma | TERMINATED | NCT02030483 |
| Dexamethasone | Other | Phase PHASE1 | Multiple Myeloma | TERMINATED | NCT02030483 |
| Palbociclib | Other | Phase PHASE1 | Multiple Myeloma | TERMINATED | NCT02030483 |
| Lenalidomide | Other | Phase PHASE1 | Multiple Myeloma | TERMINATED | NCT02030483 |
| Dexamethasone | Other | Phase PHASE1 | Multiple Myeloma | TERMINATED | NCT02030483 |
| Palbociclib | Other | Phase PHASE1 | Multiple Myeloma | TERMINATED | NCT02030483 |
| Lenalidomide | Other | Phase PHASE1 | Hodgkin Disease | COMPLETED | NCT01207921 |
Total products: 472